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Background: Obesity is a major public health problem in developing countries. Obesity a
state of excess adipose tissue mass is associated with number of cardiovascular disease
and metabolic disturbances. Irrespective of etiology, Obesity is associated with
autonomic dysfunction and contributes to obesity related comorbidities such ad insulin
resistance, hypertension, dyslipidemia and cardiovascular dysfunction.
Aim and Objective: To compare lipid profile and autonomic function between obese and
normal subjects and to assess the association of anthropometric indices and lipid profile
parameters on autonomic function.
Materials and Methods: This study included 60 subjects in the age group of 25 – 40
years. BMI > 25 kg/m2 were selected as study group. Age and sex matched, BMI of
18- 22.9 were selected as control group. Serum lipid profile estimation was done by
enzymatic method. To assess autonomicfunction status, heart rate variability at supine
rest, heart rate response to deep breathing, heart rate response to Valsalva maneuver and
blood pressure response to isometric hand grip test were carried out. Data were collected
by recording lead II ECGUsing physiopac pp8 medicated system. Short term HRV
analysis was done using Kuopio’s Finland version 2.2software. HRV parameters
Mean RR, SDNN, RMSSD, NN50, pNN50, Total power, LF nu, HF nu and LF /HF ratio
were calculated.Maximum and Minimum RR interval was noted during Deep breathing
and Valsalva maneuver. E/I ratio and Valsalva ratio were calculated. Blood pressure
response to isometric hand grip exercise was measured using manual
sphygmomanometer. The correlation ofanthropometric indices and lipid profile
parameterswith autonomic function test was also carried out.
Results: Unpaired student independent‘t’ test and spearman correlation coefficient was
usedfor statistical analysis. Triglycerides, total cholesterol and LDL were significantly
higher in obese group in comparison to control group whereas HDL was reduced in obese
group. There was significant increase in the mean heart rate, LF nu and LF/HF ratio in
obese group whereas Mean RR,SDNN, RMSSD, NN50, pNN50, total power. HFnu were
significantly lower in obese group (p<0.05).E/I ratio and valsalva ratio were also
significantly decreased in obese group compared to control(p<0.05).Resting blood
pressure was higher in obeseindividuals but in response to isometric hand grip was
significantly lowered compared to control. Spearman’s correlation showed significant
correlation of autonomic function with some anthropometricindices and lipid profile
parameters.
Conclusion: The study demonstrates HRV indices indicating sympathetic activity were
increased where those indicating parasympathetic activity were decreased. E/I ratio and
valsalva ratio indicating the parasympathetic function were also reduced. The results
suggestive of reduced parasympathetic activity associated with elevated sympathetic
activity in obese males at rest.This sympathovagal imbalance makes them susceptible for
development of cardiovascular disorders.
Keywords: Obesity, Lipid profile, Autonomic function and Heart rate variability.
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INTRODUCTION 
  
Obesity is a global epidemic which possess significant health hazard to 
human. It has been called as “New world syndrome”1. Obesity is defined by 
WHO as “abnormal or excessive collection of fat in the body to the extent that 
the health is impaired”2 and further described that there is increasing trend in 
global epidemic of overweight and obesity as “Globesity”3. It is expressed in 
terms of body mass index (BMI). About 5% of Indian populations are morbid 
obese, emerging as a major health challenge. In India prevalence rises 
especially in urban areas followed by the urban slums and lower in rural 
populations4. 
Obesity a complex disease arising from interactions of genetic and 
environmental factors. It is associated with metabolic and cardiovascular 
diseases which is responsible for about 3 lakhs deaths in Asian population5. 
Obesity is also characterized by abnormal lipid profile of increase triglycerides 
(TGL), decrease high density lipoprotein (HDL) and increase low density 
lipoprotein (LDL) concentration which increases cardiovascular risk6. Apart 
from cardiovascular risk, the increase in prevalence of obesity predisposes to 
other co-morbidities including type 2 diabetes mellitus, autonomic dysfunction 
and certain cancer.  
Autonomic nervous system (ANS) is involved in the control of 
cardiovascular system and energy metabolism by which it regulates 
bodyweight. Hypothalamus - regulatory center of satiety and of the ANS 
2 
 
becomes deranged, resulting in ANS dysfunction and obesity1.  Obesity again 
has a great impact on the Autonomic nervous system in the form of increased 
sympathetic and decreased parasympathetic activity.  Increased sympathetic 
activity leads to endothelial dysfunction, increase vasomotor tone, chronic low 
grade inflammation, hypertension and insulin resistance which acts as risk 
factors for cardiovascular dysfunction. Decreased parasympathetic activity 
increases heart rate and reduces Heart rate variability 5.  
Autonomic dysfunction in combination with abnormal lipid profile in 
obesity promotes inflammation, oxidative stress and atherosclerosis and 
lowers threshold for ventricular arrhythmia which increases risk of sudden 
cardiac death.  As per Framingham Heart study, in obese men the incidence of 
cardiac failure leading to sudden death is more common7. So this study is 
carried out in obese male individuals. 
Hence the aim of this study is to evaluate the cardiovascular risk factors 
in obese male individuals based on their lipid profile status and cardiovascular 
autonomic function tests (AFT). AFT includes Resting Heart rate variability 
(HRV), Heart rate changes during one minute controlled deep breathing 
(DBT), Valsalva maneuver (VM) and Sustained isometric hand grip test 
(SIHG). HRV is the physiological phenomenon of variation in the time 
interval between heart beats. It reflects the activity of sympathetic and 
parasympathetic system on sinus node of the heart and reduced HRV implies 
autonomic imbalance. 
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OBESITY 
Hippocrates noted “sudden death is more common in those who are 
naturally fat than in the lean”. 
Galen et al elaborated on different degrees of obesity as moderate or 
common obesity and severe or morbid obesity8. 
Obesity an excessive accumulation of body fat results in generalized 
increase in body mass index. BMI is derived by Quetelet’s index as weight in 
kilograms divided by the square of the height [weight (kg)/height (m2)] 2. It is 
related to body fat percentage and total body fat. It is the most useful method 
to estimate prevalence of obesity in a population level. Because of association 
between BMI and adiposity it has been internationally accepted to assess 
weight related health risk 9. 
ASIAN PACIFIC GUIDELINES FOR OBESITY (BMI in Kg/m2)4, 10 
As per the guidelines, Obesity is classified as follows, 
x Underweight < 18.5 has low risk for co-morbidities 
x Normal weight 18.5-22.9 has average risk for co-morbidities 
x Overweight:  23, further classified as 
x At risk for obesity 23-24.9 has increased risk for comorbidities 
x Obese I 25-29.9 has moderate risk for comorbidities 
x Obese II  30 has severe risk for co-morbidities. 
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BMI Cut-offs of obesity for Adult Europids in (kg/m2)10: 
As per this, the criteria for obesity 
x Underweight <18.5 with low risk for co-morbidities. 
x Normal weight18.5-24.9 with average risk for co-morbidities. 
x Over weight 25 is further classified as 
x Pre obese 25-29.9 with increased risk for comorbidities 
x Obese I 30-34.9 with moderate risk for co-morbidities 
x Obese II 35-39.9 with severe risk for co-morbidities 
x Obese III 40 with very severe risk for co-morbidities 
Other classification of obesity 
Based on distribution of fats, obesity is classified as  
Central or Android Obesity:  
They are more risk for cardiovascular and metabolic complications and 
it is common in men. 
Peripheral or Gynecoid Obesity:  
They are less risk for cardiovascular and metabolic complications and it 
is common in women4. 
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South Asian trait of people has higher percentage of body fat and 
increased cardiovascular risk at lower BMI compared with Caucasian 
population11. Asian cutoff of BMI for overweight is 23 kg/m2 and obesity 
is25kg/m2. The present study was conducted based on Asian pacific 
guidelines for obesity4, 10. 
South Asians has more centralized distribution of fat and high 
prevalence of abdominal obesity. Previous studies have proposed that waist 
circumference (WC) as well as waist hip ratio (WHR) estimates the abdominal 
obesity and cardiovascular risk12. Hence in this study, WC and WHR are 
compared between obese and normal groups. However preferred measure 
of abdominal obesity is WC compared with WHR ratio10.  
Waist circumference cut off values of abdominal obesity for  
Asian male and female is 90 cm and 80cm11. 
ETIOPATHOGENESIS OF OBESITY 
Obesity is due to imbalance between one’s energy intake and energy 
expenditure. 
Energy intake 
A complex physiological system integrates signals from peripheral 
organ to brain to control energy intake and energy expenditure. Signals may 
be neural, metabolic and hormonal. 
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 Food intake is influenced by factors integrated in the Hypothalamic 
Arcuate nucleus (ARH). There is a balance between interactions of two sets of 
neurons in hypothalamus. 
          Neurons secreting Agouti- related peptides (AgRP) and Neuropeptide Y 
(NPY) that increases food intake and reduces energy expenditure. 
Neurons secreting Pro-opiomelanocortin (POMC) and Cocaine-and 
amphetamine-regulated transcripts (CART) that decreases food intake and 
increases energy expenditure13. 
 Neural signals concerned with satiety reach the brainstem and controls 
food intake. Metabolic signals like decrease plasma concentrations of glucose, 
amino acids and fatty acids stimulate food intake by interacting with nervous 
system. This is known as Glucostatic theory of hunger and feeding regulation, 
aminostatic and lipostatic theories of regulation. When blood sugar level rises, 
discharge rate of glucoreceptor neuron in the satiety center of ventromedial 
nuclei of hypothalamus increases but discharge rate of glucosensitive neuron 
in the hunger center of lateral hypothalamic nuclei decreases. Nutrients also 
stimulate the release of hormones that controls food intake14.  
Role of adipokines 
There are many biologically active substances secreted by the adipose 
tissue called adipokines like Leptin, Resistin, Adiponectin, Free fatty acids, 
TNF alpha, IL-6 etc. Of all hormonal signals, secreted from adipose tissue, 
Leptin regulates energy intake by acting on arcuate nucleus of hypothalamus. 
It also regulates energy expenditure by sympathetic nervous system 
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stimulation. Leptin decreases the food intake by stimulating POMC and  
Į-MSH formation and by inhibiting the expression of NPY and Ag RP13, 14. 
Leptin resistance in satiety center of hypothalamus is a proposed 
mechanism for obesity as it increases food intake, thereby resulting in a 
vicious cycle6, 15.  
Other hormones participating in regulation of food intake include, 
Insulin secreted by pancreas which binds to receptors in arcuate nucleus of 
hypothalamus decreases food intake by stimulating leptin release. CCK 
secreted from small intestine acts rapidly and   decreases food intake. Peptide 
YY secreted from GIT decreases the appetite. Corticotrophin releasing 
hormone, nor epinephrine and serotonin also decreases food intake. Ghrelin an 
endogenous ligand of growth hormone secretagogue released by 
gastrointestinal tract stimulates food intake and carbohydrate utilization. 
Orexin A and B, Endorphins, Melanin concentrating hormone (MCH),  
Amino acids (glutamate and Ȗ -amino butyric acid), Galanin (GAL), Cortisol 
and Endocannabinoids increases food intake. Obestatin and ghrelin, 
synthesized from same precursor protein have opposite effect. Obestatin 
decreases food intake whereas ghrelin increases food intake16. 
Energy Expenditure 
It includes basal metabolic rate, energy cost of metabolizing food 
during physical activity and adaptive thermogenesis. Resting or Basal 
metabolic rate accounts for 70% whereas physical activity for 5-10 % of daily 
energy expenditure13. Thus the significant component of consumption of 
energy is fixed. During sleep it falls about 10% and during prolonged 
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starvation up to 40%17. Adaptive thermogenesis occurs in brown adipose 
tissue. This process produces more heat and less ATP by utilizing 
mitochondrial uncoupling protein (UCP-1) that uncouples oxidative 
phosphorylation from electron transport and is regulated by sympathetic 
activity.   
Genetic Factors 
Genetics plays role in body weight regulation by regulating energy 
expenditure, thus 30-40% variance in daily energy expenditure is influenced 
by genotype18. Certain genetic background individuals are prone for obesity 
especially when exposed to modern lifestyle. Genetic contribution to obesity 
has shown in Twin studies, adoption studies and family studies19.  
Genetic studies in mice demonstrated obesity due to mutation of at least 
5 identified genes – ob (obesity) gene encoding Leptin, db (diabetes) gene, 
tubby, agouti yellow and fat genes. In ob/ob mice, leptin gene is defect and in 
db/db mouse leptin receptor are defect. In majority of obese population leptin 
resistance might be one of the main reasons for obesity, though they have 
normal leptin and leptin receptor20. 
Severe obesity commencing in childhood without developmental 
abnormalities are due to mutations arising in molecule involved in  
Leptin–Melanocortin signaling pathway. Such as Leptin gene mutation 
[lepob)], Leptin receptor gene mutation [lepR(db)], Pro-opiomelanocortin  
gene mutation (POMC), Prohormone convertase 1 gene mutation (PCSK1) 
and Melanocortin 4 receptor gene mutation (MC4R)13. There are about 30 
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Mendelian disorders in which obesity is associated with developmental 
abnormalities, like mental retardation, dysmorphic features. They are Prader-
Willi Syndrome, Bardet-Biedl Syndrome, Fragile X syndrome, Cohen’s 
syndrome, Albright Hereditary Osteodystrophy and BDNF/TrKB deficiency. 
Endocrine disorders like Cushing syndrome, polycystic ovarian disorder and 
some drugs like Anticonvulsants, Anti-hypertensive drugs are also associated 
with obesity. 
Environmental factors 
Although genetics influences the body weight regulation21, Current 
obesity epidemics is result of environmental and behavioral factors interacting 
with genetic susceptibility22. Incidence of obesity increases due to 
“Obesogenic” environment that promote overeating, easy availability of 
palatable energy dense foods together with reduced energy expenditure23. 
WHO Consultation on Obesity concluded that behavior and environmental 
factors play a major role for the past two decades9.                                                            
LIPID METABOLISM 
Exogenous Pathway 
Dietary lipids are absorbed in small intestine as chylomicrons. 
Lipoprotein lipase (LPL) hydrolyses the triglycerides of chylomicrons to 
release free fatty acids (FFA). The free fatty acids released are oxidized in the 
muscles or adipose tissue to produce energy. It is also stored as triglycerides 
by re-esterification. 
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Endogenous Pathway 
Fatty acids released by lipolysis of adipose tissue are reassembled in the 
liver as Very low density lipoprotein (VLDL) which is secreted into the 
plasma. VLDL are metabolized by lipoprotein lipase to form IDL and 
converted into LDL by hepatic lipase.  
HDL Metabolism  
To maintain homeostasis liver excretes excess cholesterol as bile. Liver 
and intestine produces nascent HDL. Nascent HDL acquires free cholesterol 
from peripheral tissue and gets esterified by Lecithin cholesterol 
acyltransferase forming mature HDL. Cholesterol from mature HDL is 
transferred to VLDL and chylomicrons by cholesterol ester transfer protein 
and then back to liver. 
Role of Adipose Tissue in Lipid Metabolism-Triglyceride storage and 
lipolysis 
Adipose tissue is the energy storage organ. Exogenous dietary lipids 
called chylomicrons and endogenous VLDL are acted by lipoprotein lipase to 
release free fatty acids, which are stored as triglycerides in adipose tissue. 
Hormone sensitive lipase (HSL) hydrolyzes triglycerides into fatty acids for 
energy. Thus there is a balance between triglyceride storage and lipolysis 
generally which is influenced by complex hormonal and neuronal mechanism. 
Rate of lipolysis and level of fatty acids in plasma varies within and between 
subjects which is due to dose response effect of insulin and catecholamine on 
lipolysis and absence of feedback regulation of insulin and catecholamine 
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level by free fatty acids. Insulin and catecholamine are major hormones that 
influence lipolysis. Insulin inhibits lipolysis through its effect on hormone 
sensitive lipase whereas catecholamine stimulates lipolysis. In extremely 
obese adult’s adipocyte mass increases about four times with lipid content 
about twice 11. 
Effect of obesity on Lipid Metabolism 
In obese individuals, basal fatty acids concentration increases because 
expanded adipose tissue releases more FFA or FFA clearance is reduced 11. In 
abdominal obesity, visceral fat shows less sensitivity to anti-lipolytic effect of 
insulin  and more sensitivity to lipolytic effect of catecholamine, so it 
stimulate lipolysis via beta-3 receptor. The excess free fatty acids in plasma 
increases hepatic uptake and triglyceride rich VLDL synthesis. Also decrease 
LPL activity associated with insulin resistance slows down the normal 
clearance of VLDL24. Thus increased triglyceride rich VLDL in liver favours 
exchange of triglycerides and cholesterol ester between VLDL, HDL and LDL 
such that triglyceride rich HDL particles are formed which are rapidly 
hydrolyzed and cleared. 
 In hypertriglyceridemia, cholesterol ester transfer protein reduces the 
cholesterol-ester concentration of LDL and increases the triglyceride 
concentration of LDL. The elevated triglyceride concentration within the LDL 
is acted upon by hepatic lipase, which results in the formation of small dense 
LDL particles25. Small dense LDL is more prone for oxidation due to 
decreased free cholesterol. Small dense LDL is slowly metabolized and plays 
a major role in the development of atherosclerosis and cardiovascular disease. 
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Obesity with such abnormal lipid profile of increase in triglycerides, decrease 
in HDL and abnormal small LDL increases the cardiovascular risk26, 27. Hence, 
we intended to evaluate the synergistic risk of obesity with abnormal lipid 
profile in this study.  
Obesity and Metabolic syndrome 
 The adipose tissue acts as the culprit in insulin resistance and metabolic 
syndrome. Among the adipokines, Leptin, Adiponectin, Resistin, TNF alpha 
and RBP2 has great effect on insulin resistance. With excess fat mass, leptin 
increases and suppresses insulin production. Adiponectin increases insulin 
sensitivity. When plasma concentration of adiponectin decreases in obesity, 
insulin resistance occurs. Resistin, Retinol binding protein 2, TNF alpha and 
IL-6 also increases in obesity and contributes to insulin resistance11. 
Hyperinsulinemia as result of insulin resistance in obesity, acts on sympathetic 
nervous system contributes to hypertension and further adverse consequences.  
Criteria for Clinical Diagnosis of Metabolic Syndrome: 
1. Abdominal obesity (WC90ௗcm for Asian male or 80ௗcm for Asian 
female), 
2. Triglycerides more than or equal to 150ௗmg/dl, 
3. HDL cholesterol less than or equal to 40ௗmg/dl for male and 50ௗmg/dl 
for female,  
4. Systolic/diastolic blood pressure more than or equal to 130/85ௗmmHg 
and  
5. Fasting plasma glucose more than or equal to 100ௗmg/dl. 
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As per Revised National Cholesterol Education program Adult 
Treatment Panel III ((NCEP ATP III) criteria at least three of the following 
components are required for diagnosis of metabolic syndrome. Abdominal 
obesity is not a prerequisite for diagnosis, 28 but a component of the metabolic 
syndrome. 
AUTONOMIC NERVOUS SYSTEM 
The term “Autonomic nervous system” was proposed by Langley 
(1852-1925)29. It is a peripheral nervous system that controls heart rate, 
arterial pressure, respiratory rate, GI secretions and motility, sweating, body 
temperature, pupillary dilation, bladder emptying and sexual arousing. Though 
ANS functions autonomously, it is also influenced by higher center especially 
the hypothalamus and medulla oblongata that receive inputs from the limbic 
system and other cortical regions 14. ANS response is mediated by sympathetic 
and parasympathetic division. Sympathetic nervous system (SNS) 
predominates in energy mobilization and utilization and the parasympathetic 
nervous system (PNS) in energy restoration and storage. Thoracic-lumbar 
outflow T1-L2 is considered to be sympathetic and cranio-sacral outflow is 
considered to be parasympathetic30. All preganglionic fibers are cholinergic in 
both sympathetic and parasympathetic system whereas most of the 
postganglionic sympathetic neurons are adrenergic and most of the 
postganglionic parasympathetic neurons are cholinergic. However 
postganglionic sympathetic fibers to the piloerector muscles of the hairs, to the 
sweat glands and some skeletal muscle blood vessels are cholinergic17. 
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Autonomic Innervation and action on the Heart and Blood Vessels 
Heart has drawn its sympathetic innervations from neurons in the 
intermediolateral horn of upper five thoracic segments of spinal cord. It 
innervates cardiac muscle tissue mainly atrial and ventricles. Noradrenaline 
from sympathetic nerve acts via beta1 adrenergic receptor by increasing 
calcium conductance decreases the threshold of firing of sinoatrial node and 
increases the heart rate. Parasympathetic originates from medulla in Dorsal 
motor nucleus and Nucleus Ambiguus innervates myocardial tissue 
predominantly sinoatrial node, atrioventricular node and conducting system. 
Acetylcholine from parasympathetic nerve acts via M2 muscarinic receptor by 
increasing the potassium influx increases the threshold of sinoatrial node firing 
and decreases the heart rate 17. 
Normally, at rest there is good tonic vagal discharge (vagal tone) and 
moderate amount of sympathetic discharge to heart. Noradrenergic 
sympathetic fibers innervate blood vessels. Neurotransmitters such as 
Noradrenaline predominantly acts via alpha1 receptors mediate 
vasoconstriction whereas Adrenaline mediates its action via both alpha and 
beta 2adrenergic receptors with predominate vasodilation. Thus sympathetic 
plays a role in circulation whereas parasympathetic in cardiac functions.  
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FIGURE: 1 CONDUCTING SYSTEM OF HEART 
 
 
 
 
 
 
 
 
Brain centers for cardiovascular regulations: 
Sensory Nucleus for Autonomic nervous system is Nucleus of the 
tractus solitarius (NTS) located bilaterally in lateral portion of the medulla is 
the first relay station which receives sensory information from circulatory 
system via glossopharyngeal and vagus nerve modify the activities of both 
cardiovascular excitatory area and cardiovascular inhibitory area. 
Cardiovascular excitatory area is in rostral ventrolateral medulla (RVLM). 
Neurons in this area project to intermediolateral grey column of spinal cord 
where sympathetic vasoconstrictor fibers originates. It is important to note that 
neurons in this area (RVLM) provide excitatory drive to vasoconstrictor fibers 
to maintain basal sympathetic tone of blood vessels. Cardiovascular inhibitory 
area is in Nucleus Ambiguus and Dorsal motor nucleus of vagus in medulla 
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transmits parasympathetic impulse to heart, decrease heart rate and ventricular 
contraction31.  
Effect of obesity on Autonomic nervous system 
In obese individuals, the function of autonomic nervous system is 
commonly altered. There is increased oxidative stress in obesity which 
decreases insulin sensitivity thereby increases the circulating insulin level and 
the sympathetic activity. Landsberg32 et al originally postulated that enhanced 
autonomic activity in obesity is related to high insulin level, as it acts directly 
on hypothalamus to activate sympathetic nervous system33. Adipose tissue in 
excess releases excess leptin in obese, activates central sympathetic flow and 
further it increases adrenal medullary release of noradrenaline and its 
activity34, 35.  
Obesity is an inflammatory state it produces cytokines like  
8-isoprostane, IL-12, IL-6, CRP and TNF-Į stimulates hypothalamic pituitary 
adrenal axis to release glucocorticoids and adrenaline which in turn increases 
the sympathetic nervous system activity36,37. Hyperinsulinemia (or) insulin 
resistance also causes damage to microcirculation in many tissue including 
nerves at level of cardiac muscle or vascular wall resulting in parasympathetic 
impairment38. This increased sympathetic activity and decreased 
parasympathetic activity are associated with attenuation of baroreflex response 
in obesity. Baroreflex response is influenced by BMI, age, autonomic nervous 
system and arterial distensibility. In obesity, decreased arterial wall 
compliance due to atherosclerosis also reduces baroreflex response 39.  
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Factors causing increase cardiovascular risk in obesity 
In obesity, increase sympathetic activity, through ȕ-adrenergic 
stimulatory and vasoconstrictor effect causes reduction in muscular blood flow 
contribute to insulin resistance. Insulin resistance and hyperleptinemia in 
obesity down regulate endothelial NO synthase whereas hyperinsulinemia  
upregulate endothelin-1activity cause hypertension and further consequences 
in obesity. Adipocytokines from adipose tissue regulate the synthesis of  
pro-inflammatory cytokines leptin, TNF-Į, IL-6 and anti-inflammatory 
cytokines adiponectin and resistin. In obesity there is imbalance between two, 
increases cardiovascular risk. CRP is a marker of inflammatory state and 
endothelial dysfunction is found to be increased in obese individuals40.  IL-6 
increases in proportion to body fat and stimulates prothrombotic events36. 
Thus Hyperglycemia, Hypertension, Coagulation defects and Dyslipidemia 
increases the risk of coronary artery disease. 
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FIGURE: 2 RISK FACTORS OF CARDIOVASCULAR DISEASE IN 
OBESITY 
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CARDIOVASCULAR AUTONOMIC FUNCTION TESTS 
In Previous studies, sympathetic nervous system activity is assessed by 
measuring plasma and urinary catecholamine concentration41. Muscle nerve 
sympathetic activity is recorded using microneurography (MNSA). But has 
limitations as sympathetic out flow to skeletal muscle may not reflect 
sympathetic activity in other organs such as the heart and kidneys. In 1970s, 
Ewing et al42,43 proposed a reliable, non-invasive, simple bedside 
Cardiovascular autonomic function test to diagnose as well as monitor 
autonomic nerve involvement. Mostly they rely on cardiovascular changes 
such as Heart rate (HR) and Blood pressure (BP) response to postural changes, 
carotid sinus massage, heart rate variation to deep breathing and valsalva 
maneuver, sustained isometric hand grip and cold pressor test.  
Parasympathetic function test are 
Heart rate response to Standing: (30:15ratio) 
On standing heart rate increases and reaches its maximum at 15th beat 
(approximately 12 seconds) due to vagal withdrawal and increase sympathetic 
tone and it progressively slows down reaches minimum at 30th beat 
(approximately 20 seconds) after standing and then it gradually rises again. 
The ratio of maximum R-R intervals corresponding to the 30th beat and the 
minimum RR intervals corresponding to the 15th beat is called 30:15ratio. i.e., 
RRmax30/RRmin15 44. 
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Heart rate changes during one minute controlled deep breathing 
Normally heart rate varies from beat to beat as vagal activity 
synchronous with the respiratory cycle (Respiratory sinus arrhythmia).  
At inspiration, vagal withdrawal and increased venous return stretch atrial 
receptors to produce tachycardia. Conversely at expiration, vagal activity and 
decreased venous return reduces heart rate. It asses the cardiac vagal activity 
and it is influenced by age, rate and depth of respiration44. 
Expiration/inspiration:  longest R-R during expiration  
    shortest R-R during inspiration  
Heart rate changes during Valsalva maneuver 
It is performed by exhaling forcefully through a mouth piece connected 
to a mercury manometer for 15 or 20 seconds with mercury column 
maintained at 40mmHg. Hemodynamic changes in Valsalva maneuver divided 
into 4 phases as  
 During phase I, at the onset of straining, arterial pressure rises 
transiently due to compression of the aorta and is accompanied by reflex 
decrease in heart rate. 
 During early part of the phase II, (at expiratory phase of the Valsalva 
maneuver) as the subject blows forcefully through the mouthpiece against 
resistance, intrathoracic pressure raises and venous return, cardiac output and 
arterial pressure falls accompanied by increase in heart rate due to 
parasympathetic withdrawal and increased sympathetic outflow. In the latter 
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part, after few seconds arterial pressure begins to recover and rise above 
baseline. 
During phase III, on the cessation of straining intrathoracic pressure 
falls and pulmonary venous capacitance raises, arterial pressure decreases 
further accompanied by a reflex increase in heart rate. 
 During Phase IV with further release of strain there is an increase in 
arterial pressure above the base line i.e., overshoots due to increase in venous 
return and cardiac output. It is accompanied by reflex bradycardia  followed 
by a gradual return of heart rate to base line as blood pressure normalizes. The 
bradycardia in this phase is vagaly mediated. 
Thus Phase I and III are due to mechanical factors. Phase II and IV are 
the consequence of sympathetic, vagal and baroreflex mechanism45.  
 Valsalva ratio:  Maximum RR interval during phase IV  
      Minimum RR interval during phase II. 
Tests for sympathetic function 
Blood pressure response to Standing (Orthostatic tolerance test) 
Measure blood pressure using sphygmomanometer manually in the 
lying position and then ask the subject to stand then repeat BP measurement 
immediately. Difference of the systolic blood pressure was calculated, a fall of 
systolic BP more than 30 mmHg is abnormal43. 
 
22 
 
Blood pressure response to Valsalva maneuver 
Beat to beat blood pressure was recorded during Valsalva maneuver. 
Sympathetic failure is characterized by profound decrease of BP in phase II 
and an absence of blood pressure overshoot in phase IV of Valsalva 
maneuver45. 
Cold pressor test (CPT) 
While hand or foot is immersed in ice water there is reflex arteriolar 
vasoconstriction produces rise in arterial pressure triggered by cutaneous pain 
receptors. Blood pressure rises mainly due to enhanced sympathetic activity 
and increase vascular resistance45.  
 Sustained isometric hand grip test (SIHG) 
The pressor response to the isometric exercise is mediated by central 
command and exercising muscles. There is increase sympathetic discharge to 
the heart and muscle during exercise. This causes peripheral vasoconstriction 
in some non-contracting tissue and heart rate dependent increase in cardiac 
output and blood pressure44.  
HRV BACK GROUND (Task Force 1996)46 
Besides this conventional autonomic function test, Heart rate variability 
acts as a noninvasive tool to assess cardiovascular autonomic function. HRV 
refers to the oscillation in the interval between consecutive heartbeats as well 
as the oscillation between consecutive instantaneous hear rate. It reflects the 
sympathetic and parasympathetic activity on sinus node of the heart and 
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instantaneous HR or RR interval is the sum of these inputs. HRV analysis is 
performed under linear methods in time domain and frequency domain 
methods.  
Time domain methods 
In this method, LEADII ECG is recorded continuously, each QRS 
complex is detected and normal-normal (NN) intervals, the intervals between 
adjacent normal QRS complex (or) instantaneous heart rate are determined. 
SDNN: the standard deviation of normal-normal intervals. It is often 
calculated over a 24 hour period, express parasympathetic activity. 
SDANN: the standard deviation of the average normal-normal intervals 
calculated over short periods usually 5 minutes. 
RMSSD: the square root of the mean squared differences of adjacent NN 
intervals. 
NN50: the number of pairs of successive NN intervals that differ by greater 
than 50ms. 
pNN50: Proportion of NN50 divided by total number of NN intervals  
Frequency Domain Methods 
 In Short term recordings of about 5 minutes, Frequency domains 
methods are generally done and following components have been defined:- 
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x Low frequency component (LF) between 0.04 and 0.15Hz  
Indicates mainly sympathetic activity or combination of both 
sympathetic and parasympathetic activity 
x High frequency component (HF) between 0.15and 0.4Hz 
Reflects parasympathetic activity, oscillations depend primarily on 
respiration. 
x Very low frequency component (VLF) between 0.0033 and 0.04Hz 
Whose origin is not clear it may be due to thermal regulation of body’s 
internal systems. 
x Ultra-low frequency component (ULF) between 0 and 0.0033Hz is 
always expressed in 24hrs recording and show day-night variations. 
LF-HF ratio: 
It is the ratio of low-to-high frequency spectral power reflects 
sympathovagal balance. This is controversial due to lack of understanding of 
the mechanisms for the LF component. The measurement of VLF, LF and HF 
power components usually made in absolute values of power (milliseconds 
squared). LF and HF measured in normalized units may represent the relative 
value of each power component in proportion to the total power minus VLF 
component. Total power is the ultimate measure in power spectral density, an 
indicator of autonomic modulation as a whole. 
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FIGURE: 3 GENESIS OF HRV 
 
Recording requirements 
ECG Signal 
Fiducial point of the QRS complex of the Lead II ECG is identified 
based on the maximum or baricentrum of the complex. It is difficult to identify 
the QRS complex fiducial point if an upper-band frequency cutoff is lower 
than the established frequency band for diagnostic equipment (200Hz) and this 
may introduce an error in measured RR intervals. Error introduced in HRV 
spectrum due to limited sampling rate can be decreased by interpolation of the 
under sampled ECG signal. Hence, when there is an appropriate interpolation 
even 100 Hz sampling rate will be adequate. 
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REVIEW OF LITERATURE 
 
x 1528, Galen showed sympathovagal trunk 
x 1898, Langley introduced Autonomic nervous system. 
x 1920, Hering found the existence of Baroreflex activity 
x 1948, Alquist found the receptors and Sympathetic nervous system. 
x 1966, Albert B Lewin observed heart rate changes during Valsalva 
maneuver. 
x 1965, Hon and Lee first recognized the clinical relevance of HRV when 
they noted the fetal heart rate changes during fetal distress. 
x 1970, Ewing and Clark devised simple noninvasive tests using 
cardiovascular tests to assess autonomic dysfunction. 
Jong Weon Choi1et al (2002)47 investigated relationship between 
anthropometric parameters, total body fat and serum lipid profile and reported 
that correlation between serum lipid profile and total body fat were better than 
BMI.  
Walton C et al (1995)48 observed that fat distribution is highly 
associated with elevated total serum triglycerides and decreased HDL. 
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Stephen R et al (1999)49 Studied that fat distribution has significant 
correlation with cardiovascular risk factors than percent body fats, particularly 
android fat distribution. 
 Savva1 et al (2000) 50 validated that waist height ratio and waist 
circumference are good predictors of cardiovascular risk than BMI.  
 Guenther Boden et al (2008)51 evidenced that free fatty acids causes 
both insulin resistance and inflammation, a link for the development of risk 
component for atherosclerotic vascular disease such as type II diabetes 
mellitus, hypertension, atherogenic dyslipidemia and disorders of blood 
coagulation .  
 Carey N. Lumeng et al (2011)52 evaluated the role of inflammation in 
the obesity complication and reframed obesity as an inflammatory condition, 
which had a wide impact on obesity associated diseases.   
Zohreh mazloom et al (2009)53 noted that obese women had 
significantly higher serum concentrations of CRP, triglycerides and 
cholesterol compared to non-obese. 
  Luisa Soares et al (2011)54 studied in obese and overweight girls the 
relationship between central fat and cardiovascular autonomic function and 
reported that increased central fat is associated with parasympathetic 
hypoactivity and sympathetic hyperactivity, independent of the total body fat. 
Aronel J et al (1995)55 supported that in non-obese subjects, 10% 
weight gain causes sympathetic over activity and reduced parasympathetic 
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activity. Conversely weight loss of 10% results decreased sympathetic and 
increased parasympathetic activity and thus the autonomic nervous system act 
to oppose weight change.  
Bernd Fruehwald et al (1999)56 demonstrated an acute stimulation of 
hypothalamus pituitary adrenal axis by supraphysiological level of insulin in 
abdominal obese. 
Scherrer U et al (1994)57 observed a relationship  between fasting 
plasma insulin concentration and sympathetic firing rate positively and 
hypothesized that sympathetic activation in overweight persons is due to 
hyperinsulinemia and further supported  it by infusing low dose of insulin in 
lean person causes marked sympathetic activation.  
Mariovaz et al (1997)58 studied sympathetic nervous system function by 
regional sympathetic nervous system activity as plasma or urinary 
norepinephrine is unable to define sympathetic nervous system function in 
obesity. They investigated sympathetic nerve activity in kidney, heart and 
hepatomesentric bed and concluded that regional sympathetic nervous system 
activity was heterogeneous, higher renal norepinephrine spill  overrate in 
obesity have implicated in the development of hypertension 
Kazuko Masuo et al  (2000)59 evaluated the mechanism of  blood 
pressure elevation in weight gain based on fasting plasma insulin, leptin and 
sympathetic nervous system then reported that sympathetic overactivity in 
weight gain is more likely associated with weight gain induced arterial 
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pressure elevation than the changes in leptin and insulin level of plasma that 
accompanies weight gain. 
Shahin Akhter et al (2010)60 conducted a study  in age and sex matched 
40 obese and non-obese individuals, 5 noninvasive cardiovascular test- 
Valsalva ratio, heart rate changes to deep breathing, heart rate changes to 
standing showed significantly lower value in obese subjects which indicates 
decreased parasympathetic nerve function and also baroreflex sensitivity. 
Arterial pressure response to isometric hand grip exercise shows lesser rise of 
DBP and Blood pressure response to standing from lying showed greater fall 
of SBP which indicates decreased sympathetic activity. 
Chin HuaFu et al (2008)61found negative correlation between 
baroreflex sensitivity and LDL cholesterol. It is due to impaired endothelium 
dependent arterial dilatation in vessel wall caused by higher lipid profile 
which changes the baroreflex capacity. 
M.Bootsma et al (1994)62 demonstrated linear relationship between LF 
and HR and thus emphasized the significance of heart rate variability as a  
non-invasive method of assessing sympathovagal balance. 
HayanoJ et al (1991)63 reported that most of the time and frequency 
domain analysis provides an accurate and common measure of cardiac vagal 
tone at rest. 
Piccirillo G (1998)64 reported that obese have increased sympathetic 
arterial pressure  variation with decreased heart rate variation , due to  high 
30 
 
plasma noradrenaline level and found low LF power of heart rate as a result of 
diminished adrenoceptor responsiveness. 
Michikazu Sekine et a (2001)65 determined relationship between obesity 
and cardiac autonomic activity in 16 healthy male children 9 non-obese and 7 
obese, reported lower TP and HF nu reflecting decreased cardiac 
parasympathetic activity and increase  LF nu and LHR reflecting increased 
cardiac sympathetic activity. 
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AIM AND OBJECTIVE 
 
AIM  
To Evaluate the Lipid profile and Cardiovascular Autonomic Functions 
in obese male individuals. 
OBJECTIVE OF THE STUDY 
To compare the lipid profile and cardiovascular autonomic function 
changes between two groups (obese male and non-obese male group). 
  To assess the impact of anthropometric indices and lipid profile 
parameters on cardiovascular autonomic functions. 
Using standard cardiovascular autonomic function test includes 
1. Heart rate variability at supine rest. 
2. Heart rate changes during one minute controlled deep breathing. 
3. Heart rate response to Valsalva maneuver  
4. Blood pressure response to Sustained isometric hand grip test.   
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MATERIALS AND METHODS 
 
STUDY GROUP 
The study group was obese male individuals without any gross 
systemic disease of BMI  25 kg/m2 attending master health checkup OPD, 
Chengalpattu Medical College and Hospital, Chengalpattu. 
Subjects were explained about the procedure. Informed and written 
consent was obtained from them. 
INCLUSION CRITERIA 
BMI  25 kg/m 2 based on Asian pacific guidelines. 
           Males of age group between 25-40 years were included. 
EXCLUSION CRITERIA 
Patient with Comorbid cardiovascular diseases such as ischemic heart 
disease, cerebrovascular disease. 
  Known diabetes mellitus, hypertension, lung disease and nephropathy. 
  Known smoker or alcoholic. 
  On any drugs affecting the autonomic function. 
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ANTHROPOMETRIC MEASUREMENTS 
Weight, height, waist circumference (WC) and hip circumference (HC) 
were measured in cm. The BMI (using Quetelet’s index) and waist hip ratio 
were calculated. 
BODY WEIGHT  
Body weight was measured without shoes with an accuracy of ±10gm 
using human adult calibrated weighing machine scale. 
HEIGHT  
Stadiometer was used to measure standard body height to the nearest 
0.5 cm without shoes with relaxing the shoulder and hanging the arms freely. 
BODY MASS INDEX 
BMI was calculated by Quetelet’s index as weight in kilograms divided 
by the square of the height in meter square [weight (kg)/height (m2)] 
WAIST CIRCUMFERENCE 
At the level of midpoint between the lower rib and iliac crest, Waist 
circumference was measured using measuring inch tape in cm. 
HIP CIRCUMFERENCE 
  At the greatest diameter at the buttock, Hip circumference was 
measured using measuring inch tape in cm. 
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WAIST HIP RATIO  
By dividing waist circumference and hip circumference, WHR was 
calculated 
CONTROLS 
Healthy normal volunteers, age and sex matched, BMI between  
 18.5-22.9 kg/m2 attending Master Health Check- up OPD, Chengalpattu 
Medical College and Hospital, Chengalpattu. 
STUDY DESIGN  
Case control study.  
EXPERIMENTAL PROTOCOL 
Fasting blood sample was drawn to estimate sugar by calorimetric 
enzymatic method. Fasting plasma glucose  126mg/dl were excluded66. On 
the same day of collection, samples were centrifuged and lipid profile was 
analyzed by methods described below in Biochemistry laboratory at 
Chengalpattu Hospital. 
x Total Cholesterol: by cholesterol oxidase peroxidase method. 
x Triglycerides: by glycerol phosphate oxidase peroxidase method. 
x HDL: by direct detergent method.  
x LDL: by Freidwalds calculation =TC-(HDL+TGL/5) 
x All are enzymatic method.  
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As per NCEP ATPIII guidelines: LDL < 100mg/dl optimal, TC < 200 
mg/dl desirable, HDL cholesterol < 40 low and   60 high, TGL< 150 mg/dl 
normal67. 
METHODOLOGY OF CARDIOVASCULAR AUTONOMIC 
FUNCTION TEST 
  Autonomic function was assessed using 4 noninvasive cardiovascular 
reflex tests. Each of the subjects was explained about the procedure and 
informed written consent was obtained. Cardiovascular reflex test were 
performed in the Research Lab of the Department of physiology, Chengalpattu 
Medical College, Chengalpattu between 8 am to 1pm in quiet room at 
temperature maintained between 25 to 28°C and the lighting subdued. 
Administration of any drugs or intravascular instrumentation was not involved 
in this test. Subjects were clearly instructed not to take any drugs, which may 
alter the autonomic functions and to avoid nicotine, coffee and cool drinks on 
the day of test. After 10 minutes of rest at lab to get accustomed to the new 
environment, history was taken and Clinical examinations were carried out to 
exclude out any acute or chronic illness and also for autonomic dysfunction. 
Resting pulse rate and blood pressure using manual sphygmomanometer were 
recorded. 
METHODOLOGY OF HRV: 
Subjects were clearly advised not to have coffee, tea or cool drinks at 
least 1½ hours prior to procedure. Before procedure individual was asked to 
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empty their bladder.  Subject was instructed to lie down in supine position 
comfortable and relaxed. 
PROCEDURE  
After cleaning the skin surface with the spirit, in the following position 
ECG electrodes were fixed properly.  
Exploring Electrode - Left shoulder/Forearm 
Exploring Electrode - Right shoulder/Forearm 
Reference Electrode - Right leg  
The electrodes were connected to PHYSIOPAC equipment. 
EQUIPMENT 
Artifact free Lead II ECG was acquired using  PHYSIOPAC PP8, 
MEDICATED SYSTEM,(INDIA) in such a way instantaneous heart rate at 
RR intervals were plotted using Kuopio’s Finland version 2.2 software on a 
Microsoft Window based PC which helps to save multiple records, calculation 
tools, automated analysis and auto report generation. Short term HRV analysis 
was done after detrending using smoothness prior method with interpolation 
frequency of 4Hz.  
i)  Heart rate variability at supine rest 
  Lead II ECG was recorded for 20 minutes with eyes closed and with 
normal quiet respiratory movement (12-16/min). 
37 
 
ii) HR changes at one minute controlled deep breathing 
Subjects were instructed to breathe slowly and deeply inspiration for 5 
seconds and expiration for 5 seconds at the rate of 6 breaths /minute, who 
are under my command to do the deep breathing. Lead II ECG recording was 
continued throughout the procedure and the entire performance was monitored 
on the screen. Maximum Respiratory Sinus Arrhythmia will be produced by 
deep breathing. E/I ratio was calculated from maximum RR intervals during 
expiration and minimum RR intervals during inspiration68.  
iii)  Heart Rate changes during Valsalva maneuver 
Baseline Lead II ECG was recorded for 15 sec then subjects were asked 
to perform maneuver to exhale forcefully through the mouth piece of 
sphygmomanometer such that Pressure was maintained in the manometer 
up to 40mmHg for 15 sec. ECG recording continued during the maneuver 
and for about 30 sec after the maneuver. Valsalva ratio was calculated from 
maximum RR intervals during phase IV and minimum RR intervals during 
phase II 44, 69.  
iv) Blood Pressure changes during Isometric Hand Grip Test 
Resting blood pressure using manual sphygmomanometer was recorded 
in sitting position then subjects were asked to press the handle of 
dynamometer in dominant hand with maximum effort. The procedure was 
repeated thrice with rest in between and the best of the three was taken - as 
Maximum Voluntary Contraction (T max). After 5 minutes of rest, subjects 
were instructed to perform the same isometric hand grip exercise in 
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dominant hand at 30% of T max for 2 minutes, at the end of 2 minutes 
blood pressure was recorded on the other hand. Changes in systolic and 
diastolic blood pressure were noted. During procedure they were asked to 
breathe normally 70. 
ETHICAL CONSIDERATIONS 
The study was approved by the Institutional Ethical Committee, 
Chengalpattu Medical College and Hospital, Chengalpattu. 
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OBSERVATION 
 
TABLE 1: ANTHROPOMETRY OF SUBJECTS  
PARAMETER GROUP N MEAN±SD STUDENT 
INDEPENDENT ‘t ‘-TEST 
Age( in years) CONTROL 30 32.37 ±2.86 t=1.449 
p=0.153 STUDY 30 33.4±2.66 
Height( in cm) CONTROL 30 167.1±3.96 t= 1.303 
p=0.198 STUDY 30 165.43±5.79 
Weight( in kg) CONTROL 30 62.5±5.16 t= 11.562 
p<0.001** STUDY 30 79.87±6.42 
BMI(kg/m2) CONTROL 30 21.73±1.64 t= 16.658 
p<0.001** STUDY 30 28.7±1.60 
WC (in cm) CONTROL 30 77.77±4.52 t= 12.353 
p<0.001** STUDY 30 89.5±2.57 
HC (in cm) CONTROL 30 88.17±4.1 t= 9.013 
p<0.001** STUDY 30 96.3±2.77 
WHR CONTROL 30 0.88±0.02 t= 8.19 
p<0.001** STUDY 30 0.93±0.02 
Anthropometric measurements are expressed as mean ± SD 
*p<0.05 is significant, **p<0.01 is highly significant 
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TABLE 2: COMPARISON OF RESTING HEART RATE AND BLOOD 
PRESSURE BETWEEN TWO GROUPS. 
 
 
PARAMETERS 
CONTROL 
(N=30) 
STUDY 
(N=30) 
STUDENT 
INDEPENDENT t -
TEST 
MEAN±SD MEAN±SD   
Mean HR(bpm) 71.38±5.35 75.09±8.00 t= 2.113 p=0.039* 
SBP (mmHg) 112.73±8.23 120.53±4.30 t= 4.602 p<0.001** 
DBP (mmHg) 71.73±7.06 76.07±4.09 t= 2.91 p=0.005** 
PP (mmHg) 41±5.84 44.47±3.13 t= 2.863 p=0.006** 
MAP(mmHg) 85.4±6.94 90.89±3.89 t=3.778 P<0.001** 
 
Data are expressed as mean ± SD, 95% confidence interval of the mean. 
*p<0.05 is significant, **p<0.01 is highly significant. 
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TABLE 3: COMPARISON OF LIPID PROFILE PARAMETERS 
BETWEEN TWO GROUPS. 
 
 
PARAMETERS 
CONTROL 
(N=30) 
STUDY (N=30) STUDENT 
INDEPENDENT 
t-TEST MEAN±SD MEAN±SD 
TC 
(mg/dl) 
162.83±10.18 179.93±10.42 t= 6.431 
p=0.001** 
TGL 
(mg/dl) 
139.13±13.15 157.43±10.40 t= 5.979 
p=0.001** 
LDL 
(mg/dl) 
90.67±7.54 105.97±8.7 t= 7.279 
p=0.001** 
HDL 
(mg/dl) 
44.63±2.63 42.57±1.74 t= 3.59 
p=0.001** 
 
Data are expressed as mean ± SD, 95% confidence interval of the mean. 
*p<0.01 is highly significant. 
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FIGURE: 4  COMPARISON OF LIPID PROFILE PARAMETERS 
BETWEEN CONTROL GROUP AND STUDY GROUP 
 
This figure shows increase TC, TGL and LDL and decrease HDL in 
study group compared to control group 
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TABLE4: COMPARISON OF HRV INDICES TIME DOMAIN 
MEASURES BETWEEN TWO GROUPS DURING SUPINE REST. 
TIME 
DOMAIN 
MEASURES 
CONTROL 
(N=30) 
STUDY 
(N=30) 
STUDENT 
INDEPENDENT  
t –TEST 
MEAN±SD MEAN±SD t value P value 
MEAN RR (ms) 848.47±59.62 810.03±85.76 2.015 0.04* 
MEAN HR 
(bpm) 
71.38±5.35 75.09±8.00 2.113 0.039* 
SDNN( ms) 33.39±12.99 23.17±9.37 3.496 0.001** 
RMSSD (ms) 26.26±10.65 17.37±7.996 3.656 0.001** 
NN50 COUNT 22.03±13.8 11.05±9.85 3.404 0.001** 
pNN50 (%) 6.2±3.81 3.19±2.81 3.473 0.001** 
 
Data are expressed as mean ± SD, 95% confidence interval of the mean. 
*p<0.05 significant,  
**p<0.01 highly significant. 
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FIGURE: 5 COMPARISON OF MEAN HR AND MEAN RR BETWEEN 
CONTROL AND STUDY GROUP AT SUPINE REST 
 
This figure shows increase  Mean HR and decrease Mean RR in study 
group compared to control group 
FIGURE: 6 COMPARISON OF TIME DOMAIN MEASURES BETWEEN 
CONTROL AND STUDY GROUP AT SUPINE REST 
 
This figure shows decrease in SDNN, RMSDD, NN50, pNN50% in 
study group compared to control group. 
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TABLE 5: COMPARISON OF HRV INDICES FREQUENCY DOMAIN 
MEASURES BETWEEN TWO GROUPS DURING SUPINE REST. 
FREQUENCY 
DOMAIN 
MEASURES 
CONTROL 
(N=30) 
STUDY 
(N=30) 
STUDENT 
INDEPENDENT t -
TEST 
MEAN±SD MEAN±SD t value P value 
MEAN RR 
(ms) 
848.46±59.62 810.03±85.76 t= 2.015 p=0.04* 
TOTAL 
POWER ms2 
1118.93±763.07 628.4±780.26 t= 2.462 p=0.017* 
LF n.u. 73.59±4.16 80.52±3.53 t= 6.96 P<0.001** 
HF n.u. 26.24±4.26 19.39±3.54 t= 6.766 P<0.001** 
LF/HF RATIO 2.89 ±0.54 4.32±0.97 t=7.045 P<0.001* 
 
Data are expressed as mean ± SD, 95% confidence interval of mean 
*p< 0.05 significant, **p< 0.01 highly significant. 
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FIGURE: 7 COMPARISON OF TOTAL POWER (ms2) BETWEEN 
CONTROL GROUP AND STUDY GROUP AT SUPINE REST 
 
This figure shows decrease Total power in study group compared to 
control group 
FIGURE: 8 COMPARISON OF LF / HF RATIO BETWEEN 
CONTROL GROUP AND STUDY GROUP AT SUPINE REST 
 
This figure shows increase LF/HF ratio in study group compared to 
control group.  
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TABLE 6: COMPARISON OF HRV INDICES AND E/I RATIO 
BETWEEN TWO GROUPS DURING ONE MINUTE CONTROLLED 
DEEP BREATHING. 
HRV INDICES 
AND 
E/I RATIO 
CONTROL 
(N=30) 
STUDY 
(N=30) 
STUDENT 
INDEPENDENT t- 
TEST 
MEAN±SD MEAN±SD t value P value 
MEAN HR 
(bpm) 
75.54±7.28 75.26±8.76 0.134 0.893 
MEAN RR (ms) 817.76±82.87 816.18±98.44 0.067 0.947 
SDNN (ms) 98.48±30.16 69.56±36.28 3.358 0.001** 
HF n.u. 35.83±10.65 30.66±7.47 2.178 0.034* 
E/I 1.28±0.10 1.19±0.11 3.4 0.001** 
 
Data are expressed as mean ± SD, 95% confidence interval of the mean. 
*p<0.05 significant,  
**p< 0.01 highly significant.  
 
 
48 
 
FIGURE: 9 COMPARISON OF E/I RATIO BETWEEN CONTROL 
GROUP AND STUDY GROUP 
 
 
This figure shows decrease E/I ratio in study group compared to control 
group. 
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TABLE 7: COMPARISON OF VALSALVA RATIO BETWEEN TWO 
GROUPS 
VALSALVA     
RATIO 
CONTROL 
(N=30) 
STUDY 
(N=30) 
STUDENT 
INDEPENDENT 
t- TEST 
MEAN±SD MEAN±SD  
MAXRR/MIN RR 
(ms) 
1.47±0.27 1.32±0.22 
t= 2.429 
p=0.018* 
Data are expressed as mean ± SD, 95% confidence interval of the mean. 
*p< 0.05 significant, 
FIGURE: 10 COMPARISON OF VALSALVA RATIO BETWEEN 
CONTROL GROUP AND STUDY GROUP 
 
This figure shows decrease Valsalva ratio in study group compared to 
control group 
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TABLE 8: COMPARISON OF ISOMETRIC HAND GRIP BETWEEN 
TWO GROUPS 
PARAMETERS 
CONTROL 
(N=30) 
STUDY 
(N=30) 
STUDENT 
INDEPENDENT 
t- TEST 
MEAN±SD MEAN±SD  
Systolic blood 
pressure difference 
(mmHg) 
12.27±4.03 10.2±2.75 
t= 2.323 
p=0.024* 
Diastolic blood 
pressure difference 
(mmHg) 
12.53±2.87 10.8±2.76 
t= 2.383 
p=0.02* 
 
 Data are expressed as mean ± SD, 95% confidence interval of the mean. 
*p<0.05 significant 
 
FIGURE: 11 COMPARISON OF ISOMETRIC HANDGRIP BETWEEN 
CONTROL GROUP AND STUDY GROUP 
 
This figure shows rise of SBP and DBP in study group is less compared 
to control group.     
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TABLE 9: CORRELATION BETWEEN BMI, WC, AND WHR AND 
SDNN, TP AND LF/HF RATIO. 
N=60 BMI(Kg/m2) WC(cm) WHR 
SDNN(ms) 
-0.336 
0.009** 
-0.303 
0.018* 
-0.246 
0.058 
TOTAL 
POWER(ms2) 
-0.405 
0.001** 
-0.347 
0.007** 
-0.291 
0.024* 
LF/HF RATIO 
0.603 
0.001** 
0.618 
0.001** 
0.51 
0.001** 
 
Data are expressed as spearman correlation coefficient r, and P value 
respectively, 95% confidence interval of R are mentioned when P values are ~ 
0.05. 
*p< 0.05 significant,  
** p<0.01 highly significant. 
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FIGURE: 12 CORRELATION BETWEEN BMI AND HRV (5 min) 
SDNN 
 
This figure shows negative correlation between BMI and SDNN. 
 
FIGURE: 13 CORRELATION BETWEEN BMI AND HRV(5 min) 
TOTAL POWER 
 
This figure shows negative correlation between BMI and Total power. 
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FIGURE: 14 CORRELATION BETWEEN BMI AND HRV(5MIN) 
LF/HF RATIO 
 
This figure shows positive correlation between BMI and LF/HF RATIO. 
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TABLE 10: CORRELATION BETWEEN BMI, WC AND WHR AND 
E/I RATIO AND VALSALVA RATIO. 
 
N=60 BMI(Kg/m2) WC(cm) WHR 
E/I RATIO 
-0.44 
0.001** 
-0.433 
0.001** 
-0.424 
0.001** 
VALSALVA RATIO 
-0.344 
0.007** 
-0.254 
0.05 
-0.22 
0.091 
 
*p< 0.05 significant 
** p<0.01 highly significant. 
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FIGURE: 15 CORRELATION BETWEEN BMI AND E/IRATIO 
 
 This figure shows negative correlation between BMI and E/I RATIO 
 
FIGURE: 16 CORRELATION BETWEEN BMI AND VALSALVA 
RATIO 
 
 This figure shows negative correlation between BMI and Valsalva 
ratio. 
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TABLE 11: CORRELATION BETWEEN BMI, WC AND WHR AND   
ISOMETRIC HAND GRIP 
N=60 BMI(Kg/m2) WC(cm) WHR 
 
 
IHG 
SBP 
difference(mmHg) 
-0.207 
0.112 
-0.166 
0.204 
-0.212  
0.104 
DBP 
Difference (mmHg) 
-0.262 
0.043* 
-0.225 
0.084 
-0.18 
0.17 
 
 Data are expressed as spearman correlation coefficient r, and P 
value respectively, 95% confidence interval of R are mentioned when P values 
are~ 0.05. 
*p< 0.05  significant. 
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FIGURE: 17  CORRELATION BETWEEN BMI AND SYSTOLIC 
BLOOD PRESSURE DIFFERENCE 
 
 This figure shows negative correlation between BMI and SBP 
difference during IHGT 
FIGURE: 18 CORRELATION BETWEEN BMI AND DIASTOLIC 
BLOOD PRESSURE DIFFERENCE 
 
 This figure shows negative correlation between BMI and DBP 
difference during IHGT. 
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TABLE12: CORRELATION BETWEEN LIPID PROFILE AND SDNN, 
TOTAL POWER AND LF/HF RATIO. 
N=60 
TC 
(mg/dl) 
TGL 
(mg/dl) 
LDL 
(mg/dl) 
HDL 
(mg/dl) 
SDNN 
(ms) 
-0.26 
0.045* 
-0.213 
0.102 
-0.285 
0.027* 
0.142 
0.278 
TOTAL 
POWER 
(ms2) 
-0.284 
0.028* 
-0.25 
0.054 
-0.322 
0.012* 
0.203 
0.121 
LF/HF RATIO 0.53 
0.001** 
0.488 
0.001** 
0.582 
0.001** 
-0.309 
0.016* 
 
 Data are expressed as spearman correlation coefficient r, and P value 
respectively, 95% confidence interval of R are mentioned when P values are~ 
0.05. 
*p< 0.05 significant, **p<0.01 highly significant. 
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FIGURE: 19 CORRELATION BETWEEN LDL AND HRV (5 min) 
SDNN 
 
 
 This figure negative shows negative correlation between LDL and 
SDNN. 
 
 
 
FIGURE: 20 CORRELATION BETWEEN LDL AND HRV(5 min) 
TOTALPOWER 
 
This figure negative shows negative correlation between LDL and Total power 
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FIGURE: 21 CORRELATION BETWEEN LDL AND HRV (5 min) 
LF/HF RATIO 
 
This figure negative shows positive correlation between LDL and 
LF/HF ratio. 
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TABLE 13: CORRELATION BETWEEN LIPID PROFILE AND E/I 
RATIO AND VALSALVA RATIO. 
.N=60 TC 
(mg/dl) 
TGL 
(mg/dl) 
LDL 
(mg/dl) 
HDL 
(mg/dl) 
E/I RATIO -0.376 
0.003** 
-0.367 
0.004** 
-0.405 
0.001** 
0.2 
0.125 
VALSALVARATIO -0.297 
0.021* 
-0.252 
0.052 
-0.27 
0.037* 
0.067 
0.61 
 
 Data are expressed as spearman correlation coefficient r, and P value 
respectively, 95% confidence interval of R are mentioned when P values are~ 
0.05. 
*p< 0.05 significant 
**p<0.01 highly significant. 
 
 
 
 
 
 
 
 
 
62 
 
FIGURE: 22 CORRELATION BETWEEN LDL AND E/I RATIO 
 
 
 
 This figure shows negative correlation between LDL and E/ I RATIO. 
 
 
 
FIGURE: 23  CORRELATION BETWEEN LDL AND VALSALVA RATIO 
 
 
 
This figure shows negative correlation between LDL and Valsalva ratio. 
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TABLE 14: CORRELATION BETWEEN LIPID PROFILE AND 
ISOMETRIC HAND GRIP. 
 
N=60 TC(mg/dl) TG(mg/dl) LDL(mg/dl) HDL(mg/dl) 
 
IHG 
SBP 
Difference 
(mmHg) 
-0.167 
0.201 
-0.097 
0.459 
-0.165 
0.209 
0.017 
0.9 
DBP 
difference 
(mmHg) 
-0.282 
0.029* 
-0.162 
0.216 
-0.251 
0.053 
0.006 
0.963 
 
 Data are expressed as spearman correlation coefficient r, and P value 
respectively, 95% confidence interval of R are mentioned when P values are~ 
0.05. 
 
*p<0.05significant 
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RESULTS 
 
 Statistical Package for Social Sciences (SPSS) 16 version was used for 
Statistical analysis. The present study includes 60 subjects (30 0bese and 30 
non-obese)  
Table 1-8 were analyzed using student independent unpaired ‘t’ test 
  Table 1: Anthropometric characteristic of subjects are expressed as 
mean ± SD  
Shows significant difference in weight, BMI, waist circumference, hip 
circumference and waist hip ratio between control group and study group, 
(**p<0.01)  no significant difference in age and height. 
  Table 2: Comparison of Resting Heart Rate and Blood Pressure 
expressed as mean± SD 
Shows significant difference in HR (* p<0.05), SBP, DBP, PP and 
MAP between control group and study group (**p<0.01). 
  Table 3: Comparison of Lipid profile parameters expressed as 
mean ± SD  
Shows significant increase in TC, TGL and LDL in study group as 
compared to control group (**p<0.01). Also shows, significant decrease in 
HDL in study group as compared to control group (**p<0.01). 
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  Table 4: Comparison of HRV indices time domain measures at 
supine rest expressed as mean ± SD  
Shows significant increase in HR and decrease in RR interval in study 
group as compared to control group (*p<0.05). Also shows, significant 
decrease in SDNN, RMSSD, NN50 and PNN50% in study group as compared 
to control group indicating decreased parasympathetic activity (**p<0.01). 
 Table 5: Comparison of HRV indices frequency domain measures 
at supine rest expressed as mean ± SD  
Shows significant increase in LF nu, LF/HF ratio in study group as 
compared to control group (**p<0.01). Also shows significant decrease in 
Total power (* p<0.05) and HF nu (**p<0.01) in study group as compared to 
control group.  
 Table 6: Comparison of HRV indices and E/I at one minute 
controlled deep breathing expressed as mean ±SD 
  Shows no significant difference in Mean HR and Mean RR between 
study group and control group. Also shows, significant decrease in SDNN 
(**p<0.01), HF nu (*p<0.05) and E/I ratio (**p<0.01) in study group as 
compared to control group 
 Table 7: Comparison of Valsalva ratio between control and study 
group expressed as mean± SD.  
Shows significant decrease in Valsalva ratio in study group as 
compared to control group (*p<0.05). 
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 Table 8: Comparison of Isometric hand grip between control and 
study groups expressed as mean ±SD.  
Shows significant decrease in rise of SBP and DBP in study group as 
compared to control group (* p<0.05).  
 The cardiovascular autonomic function test was correlated with 
anthropometric indices and lipid profile parameters by spearman 
correlation coefficient. 
 Table 9: Correlation between Anthropometric parameters and 
SDNN, TP and LF/HF ratio of Resting HRV. 
  BMI shows significant negative correlation with SDNN, TP and  
LF/ HF ratio (**p<0.01). WC also shows negative correlation with SDNN, TP 
and LF/HF ratio significantly (*p<0.05). WHR shows negative correlation 
with TP and LF/HF ratio significantly (*p<0.05) and with SDNN 
insignificantly. 
  Table 10: Correlation between Anthropometric parameters and 
E/I ratio and Valsalva ratio  
BMI shows significant negative correlation with E/I ratio and Valsalva 
ratio (**p<0.01).  WC shows negative correlation with E/I ratio significantly 
(**p<0.01) and Valsalva ratio insignificantly. WHR also shows negative 
correlation with E/I ratio significantly   (**p<0.01) and Valsalva ratio 
insignificantly. 
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 Table 11: Correlation between Anthropometric parameters and 
Isometric hand grip test 
BMI shows negative correlation with rise of DBP significantly 
(*p<0.05) and SBP insignificantly. WC and WHR also show negative 
correlation with rise of SBP and DBP insignificantly. 
 Table 12:  Correlation between Lipid profile and SDNN, TP and 
LF/HF ratio of Resting HRV. 
TC, LDL shows significant negative correlation with SDNN,  
TP (*p<0.05) and positive correlation with LF/HF ratio (**p<0.01). TGL 
shows negative correlation with SDNN, TP insignificantly and positive 
correlation with LF/HF significantly (**p<0.01). HDL shows positive 
correlation with SDNN and TP though insignificant and negative correlation 
with LF/HF ratio significantly (*p<0.05). 
 Table 13: Correlation between Lipid profile and E/I ratio and 
Valsalva ratio  
TC and LDL shows significant negative correlation with E/I ratio 
(**p<0.01) and Valsalva ratio (*p<0.05). TGL shows negative correlation 
with E/I ratio significantly (**p<0.01) and Valsalva ratio insignificantly. HDL 
positively correlated with E/I ratio and Valsalva ratio though not significant.  
 Table14: Correlation between Lipid profile and Isometric hand 
grip test .  
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           TC, TGL and LDL were negatively correlated with rise of SBP but not 
significant.TC shows negative correlation with rise of DBP significantly 
(*p<0.05). TGL and LDL also shows negative correlation with rise of DBP 
but not significant. HDL shows positive correlation with rise of SBP and DBP 
but not significant. 
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DISCUSSION 
 
          Obesity is one of the common health problems in the community.  
Obesity and its related comorbidities like metabolic and cardiovascular 
diseases increases day by day.  Though it reduces life expectancy of 
individuals, it is one of the preventable risks. In Obesity, the commonly 
altered metabolism is lipid. This abnormal lipid profile increases the risk of 
atherosclerosis and adverse cardiovascular events. Autonomic nervous system 
influences cardiovascular system under resting conditions. The heart rate and 
blood pressure is regulated by the ANS which in turn is influenced by arterial 
baroreflex mechanism.  Thereby arterial baroreflex mechanism also plays a 
role in cardiovascular regulation. Obesity and abnormal lipid profile impairs 
autonomic and baroreceptor regulation of cardiovascular system and 
predisposes to certain cardiovascular disease.  
 Hence the present study was to evaluate lipid profile and autonomic 
function test of obese male individuals using cardiovascular autonomic 
function test and to correlate anthropometric parameters and lipid profile with 
autonomic function test. According to EWING’S CRITERA, abnormal 
response in two or more of the heart rate test indicates definite Autonomic 
involvement43, 60. Cardiovascular autonomic reflex tests including Heart Rate 
Variability, Deep Breathing, Valsalva Maneuver and Isometric Hand Grip 
were carried out to quantify autonomic dysfunction. The test that asses 
parasympathetic function are time domain measures and high frequency 
70 
 
component of resting HRV, E/I ratio of  deep breathing and Valsalva ratio. 
The test that asses sympathetic function are low frequency component of 
resting HRV and Isometric hand grip test. 
CHARACTERISTIC OF STUDY SUBJECTS  
 Obese male individuals of BMI >25kg/m2 were enrolled as study group 
and normal individuals of BMI< 22.9 kg/m2 were enrolled as control group.  
The mean age of obese and non – obese individuals included in this study 
were 33.4±2.66 and 32.37±2.86, there was no significant differences. This 
shows change in autonomic nervous system activity is due to excess body fat 
rather than age.  
            The body mass index was calculated by the formula, weight in (kg) / 
Height in (m2) and Waist Hip Ratio by the formula, waist circumference/ Hip 
circumference. The mean BMI of study group and control group shows 
statistically significant difference (*p<0.01). The mean WC and WHR of 
study group and control group also shows statistically significant differences 
(*p<0.01). (Table 1) This shows altered lipid profile and autonomic activity is 
due to excess body fat.  
             According to Deepan Stephen et al49, the prevalence of generalized 
and abdominal obesity increases until the age of 50 in both the gender and 
both associated with cardio metabolic risk. According to Hirsh et al71, when 
body weight increases by 10%, there was reduced parasympathetic activity. 
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RESTING HEART RATE AND BLOOD PRESSURE 
 In this study, the mean RHR was higher in study group (75.09±8.00) 
compared to control group (71.38±5.35), significantly with (*p<0.05). 
According to Ravikeerthy et al72, (2015) Kanavi roopa shekarappa et al2, 
(2011) and Ajay et al73, (2014) resting heart rate was higher in obese group. 
Increased resting heart rate in obesity is due to reduced parasympathetic 
activity and increased sympathetic activity. 
            The mean SBP and DBP in study group were (120.53±4.30 and 
76.07±4.09) and in control group were (112.73±8.23 and 71.73±7.06) 
respectively. The mean PP and MAP in study group were (44.47 ±3.13 and 
90.89±3.89) and in control group were (41±5.84 and 85.4±6.94) respectively. 
The resting SBP, DBP, PP and MAP were significantly increased in the study 
group as compared to control group with (**p< 0.01). (Table2)  
           This is similar to findings observed in other studies conducted in 
different age group. According to Kanavi roopa shekarappa et al2, (2011) 
study, SBP, DBP, PP and MAP were significantly higher in study group 
compared to control group of age 21 to 60 years. However based on age 
distribution, they found DBP was not significant in obese in the age group of 
31 to 40 years. Ravikeerthy et al72, (2015) revealed that SBP, DBP, PP and 
MAP were significantly higher in obese group compared to non-obese group. 
Ajay et al73, (2014) also demonstrated higher BP in obese group but in 
younger age (15-19years). 
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  The higher resting SBP, DBP in obese individuals is due to increase 
vasoconstrictor tone and increase in blood volume and cardiac output as a 
result of increased metabolic demand. The metabolic demand increases as 
additional blood flow is required for extra adipose tissue. The increase in 
peripheral resistance is due to sympathetic over activity, endothelial 
dysfunction, insulin resistance and cytokines from adipose tissue. Other 
mechanisms involved in sympathetic activation and high BP may be 
hyperleptinemia, hyperinsulinemia, free fatty acids and Renin angiotensin-
aldosterone activation. (Srinath et al, 2011)74. In obesity, there is a rise of heart 
rate and blood pressure even under resting conditions which contributes to  
CV dysfunction at an earlier stage. 
LIPID PROFILE 
           Total cholesterol, Triglycerides and LDL levels were higher in study 
group (179.93, 157.43 and 105.97) as compared to control group (162.83, 
139.13 and 90.67) which was significant. Whereas HDL level was lower 
significantly in study group (42.57)  as compared to control group (44.63) with 
(**p< 0.01).(Table3)  
           The findings of the present study shows obese individuals are at high 
risk for cardiovascular disorder. According to Assadi Fatemeh et al75, (2014) 
the significantly higher value of TC, TGL, LDL and non-significant difference 
of  HDL  was observed in obese individuals  of BMI>30kg/m2. According to 
Pallavi et al27, (2015) the significant higher value of TC, TGL, LDL and 
significant lower value of HDL was observed in obese individuals but it was at 
different gender group. 
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  In obesity quality of fat is more important than quantity75.  Basal 
plasma FFA concentration is usually elevated in obesity because of increase 
release of FFA from expanded adipose tissue and decrease FFA clearance. 
These excess free fatty acids, in plasma enter to liver, primarily increases 
triglycerides and VLDL which in turn increases LDL and decreases HDL76.  
           The increased plasma FFA will inhibit anti-lipolytic effect of insulin 
and causes further release of FFA. Increase adipocyte mass especially visceral 
fat, decreases its sensitivity to antil-ipolytic effect of insulin and increases its 
sensitivity to catecholamine and facilitate lipolysis 51.  
CARDIOVASCULAR AUTONOMIC FUNCTION TEST 
RESTING HEART RATE VARIABILITY 
           Heart rate variability is a non-invasive tool to assess ANS. Any 
alteration in HRV is associated with increased risk of adverse cardiac events.  
In this study, Resting HRV of 5 minutes was analyzed by using HRV analysis 
software, university of Kuopio, version 2.2 for both the study group and 
control group. 
TIME DOMAIN MEASURES 
 Mean HR, Mean RR, SDNN, RMSDD, NN50, pNN50% 
Mean HR and Mean RR 
 The mean HR was increased in study group (75.09±8.00) compared to 
control group (71.38±5.35) significantly with (*p=0.039). According to          
Hugh R Peterson et al, heart rate was directly related to body fat percentage. 
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The heart rate increases due to sympathetic overactivity and reduced 
parasympathetic activity in obesity2.  
  The mean RR interval of study group (810.03 ±85.76) was lower on 
compared to control group (848.46 ±59.62) and it was statistically significant 
(*p=0.04). This finding was in accordance with Jaruwaplaengdee et al77, 
(2009) that the average RR interval in obese group was lower as compared to 
non- obese group. 
SDNN, RMSDD, NN50 and pNN50% 
            The standard deviation of the NN intervals (SDNN) is the simplest 
variable calculated. The SDNN was significantly decreased in the study group 
(23.17±9.37) as compared to control group (33.33±12.99) with (**p< 0.01). 
(Table 4 ) It reflects reduced parasympathetic activity in obesity. There was 
also a significant decrease in RMSDD, NN50, and pNN50 % in study group as 
compared to control group with (**p<0.01). This implies in obesity 
parasympathetic regulation reduced significantly when compared to non-obese 
individuals.  
            According to Rajalakshmi et al78, (2012) SDNN, RMSDD, NN50 and 
PNN50% were significantly lower in obese group compared to non-obese 
group. In contrast, Jaruwaplaengdee et al 77, (2009) showed non-significant 
increased SDNN in obese group and non-significant difference of RMSDD 
between obese and non-obese group. Obesity, a state of insulin resistance and 
hyperinsulinemia may decreases cardiac vagal activity and increases 
cardiovascular risk 38.  
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FREQUENCY DOMAIN MEASURES 
 TP, LF nu, HF nu and LF/HF ratio 
      Total power was decreased in obese group (628.4) as compared to  
non-obese group (1118.93) which was statistically significant with (*p<0.05) 
and it is inversely proportional to resting heart rate. It is important to recall 
that during sympathetic activation the resulting increase in HR is usually 
accompanied by a marked reduction in total power, whereas the reverse occurs 
during vagal activation.46 This is in accordance with findings of G.K pal et al5 
(2014), Rajalakshmi et al78 (2012), Ravi Kant Soni et al79 (2014) they all 
observed decreased total power in obese group as compared to control group. 
           HF nu was lower in study group as compared to control group 
significantly with (**p< 0.01).This shows the parasympathetic component was 
significantly reduced in obesity. LF nu is a marker of sympathetic activity.  
LF nu was found to be increased significantly in study group as compared to 
control group with (**p< 0.01).   
          Representation of LF/ HF in normalized units signifies the balance 
behavior of two divisions of the autonomic nervous system. LF/HF ratio is an 
accurate measure of sympathovagal balance. There was significant increase in 
LF/HF ratio in study group (4.32± 0.97) as compared to control group 
(2.89±0.54) with (**p< 0.01). (Table 5) This observation was in similar with 
findings of Anahita R Shenoy et al80 (2014), GK pal et al5 (2014), Rajalaksmi 
et al 78(2014), they all reported significantly decreased HF nu and significantly 
increased LF nu and LF/HF ratio in obese group.   
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 Significant increased LF nu and decreased HF nu shows definite 
sympathetic hyperactivity and parasympathetic hypoactivity in obesity. Higher 
value of LF/ HF ratio indicates sympathovagal balance shifting more towards 
the sympathetic component in obese group. The higher value of LF/HF ratio 
also shows more sympathetically driven cardiovascular system in obesity 
under resting conditions. This increases the work load of the heart by 
increasing heart rate and peripheral resistance. 
           Hyperinsulinemia associated with insulin resistance causes sympathetic 
over activity in obesity. This effect of insulin in long term is maladaptive, 
because it limits further weight gain and it increases the risk of hypertension, 
metabolic and cardiac abnormalities.33 Excess leptin in obesity activates 
sympathetic nervous system and also increases noradrenaline activity of 
adrenal medulla35. The subclinical inflammation associated with obesity 
produces inflammatory cytokines such as IL-6, TNF Į which also increases 
sympathetic activity36, 37. Thus it implies increase sympathetic activity in 
obese individuals is mainly is due to hyperinsulinemia or insulin resistance, 
excess leptin and inflammatory cytokines. 
           It is well obvious, that the present study shows significantly higher 
heart rate, LF nu and LF/HF ratio indicating sympathetic predominance in 
obesity. It also shows significantly lower SDNN, TP and HF nu indicating 
reduced vagal activity in obesity.  The sympathetic stimulation in obese 
individuals even under resting condition increases heart rate and force of 
contractions resulting in increased energy consumption and metabolism of 
cardiac tissue. This increases the production of metabolic waste and 
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myocardial injuries.  Also the blood vessels that are maintained in the 
sympathetic tone   normally, undergoes vasoconstriction due to increase 
sympathetic activity resulting in hypertension and further consequences in 
obesity. 
DEEP BREATHING TEST 
 HRV during timed breathing is one of the most reliable and 
reproducible marker of parasympathetic modulation of cardiac activity. The 
Deep Breathing is primarily mediated by vagal activity resulting in respiratory 
sinus arrhythmia (RSA). RSA is a change of heart rate due to respiration 
induced biochemical changes, intrathoracic pressure changes and central vagal 
stimulation81. It falls under High frequency range of HRV (0.15-0.4 Hz) which 
is mainly contributed by efferent vagal activity.  
           In our study, mean HR during deep breathing in study group and 
control group was almost the same. An increase in SDNN and HF nu in the 
control group is due to relative increase in vagal activity and decrease in 
sympathetic activity during slow breathing. The tidal volume increases to 
compensate reduced breathing rate and to maintain minute ventilation and that 
is responsible for these autonomic changes.  Respiratory sinus arrhythmia was 
blunted in study group as shown by significant decrease in SDNN and HF nu 
in study group as compared to control group. (Table 6)  
           Heart rate increases at inspiration and decreases at expiration. E/I ratio 
was calculated as the ratio of maximum RR interval during expiration to the 
minimum RR interval during inspiration at deep breathing (6 breaths per 
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minute). In this study, there was significant lower value of E/I ratio in study 
group (1.19 ±0.11) as compared to control group (1.28 ±0.10) indicating 
decreased parasympathetic activity in obesity with (**p< 0.01) (Table 6). 
Reduced HRV at one minute controlled deep breathing indicates that cardiac 
vagal activity and baroreflex response decreases in obesity. According to 
Chethan et al82 (2012), E/I ratio was decreased significantly in obese group 
compared to non-obese group. 
VALSALVA MANEUVER 
 Valsalva ratio was calculated as the ratio of maximum RR interval 
during phase IV to the minimum RR interval during phase II. In phase IV, due 
to vagal activity, bradycardia occurs and maximum RR interval is noted. In 
phase II, due to sympathetic activity and parasympathetic withdrawal, 
tachycardia occurs and minimum RR interval is noted. Though Valsalva 
maneuver predict both sympathetic and parasympathetic dysfunction, we are 
not able to predict the sympathetic component as beat to beat BP monitor is 
not available in our laboratory. Valsalva ratio was lower in study group 
(1.32±0.22) as compared to control group (1.47±0.27) significantly with 
(*p<0.05) (Table 7). This indicates decrease in parasympathetic function and 
baroreflex activity as body weight increases.   
         According to Shahin Akhtel et al 38(2008), Rinku Garg83 et al, E/I ratio 
and Valsalva ratio were significantly decreased in obese male as compared to 
normal male. This shows decreased parasympathetic activity and baroreflex 
response in obesity. The impairment of parasympathetic function in obesity 
may be due to hyperinsulinemia (or) insulin resistance that causes damage to 
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microcirculation in many tissue including nerves at level of cardiac muscle or 
vascular wall. Baroreflex activity may decreases in obesity due to ANS 
disturbances or altered arterial wall compliance (38, 83). 
ISOMETRIC HAND GRIP TEST 
 In response to isometric exercise, rise of systolic and diastolic blood 
pressure in study group (10.2±2.75,10.8±2.76) were lower as compared to 
control group(12.27± 4.05, 12.53± 2.87) which was statistically significant 
with(*p< 0.05) (Table 8).  The findings  was in accordance with srinath et al 74 
(2011), that the base line SBP and DBP were  significantly higher in obese 
group as compared to control group and rise of SBP and DBP in response to 
isometric exercise were significantly lower in study group as compared to 
control group. This borderline response to hand grip test is suggestive of 
reduced sympathetic activity in obesity when subjected to stress.   
 Cardiovascular responses to (IHGT) are mediated partly by central 
command and partly by exercising muscle or both. Exercise is a physical 
stress and is an important activity in daily life. Based on the physical exercise, 
ANS influence the heart rate and blood pressure. During isometric hand grip 
exercise in normal person, cardiac sympathetic fibers and peripheral 
sympathetic fibers gets activated.  So there is increase in heart rate and 
peripheral resistance which results in increasing arterial pressure. 
           In obesity, there is a borderline rise in pressure due to defect in cardiac 
sympathetic activation or in peripheral adrenoreceptors during isometric 
exercise. Thus in obesity there is sympathetic cardiovascular function 
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derangement in the form of increased resting SBP, DBP and decrease in rise of 
SBP, DBP in response to isometric hand grip exercise which points out 
autonomic imbalance. This autonomic imbalance increases cardiovascular risk 
in obese individuals in later part of their period 70, 84.  
CORRELATION OF ANTHROPOEMETRIC INDICES WITH 
CARDIOVASCULAR AUTONOMIC FUNCTION TEST: 
Correlation of Anthropometric Indices with SDNN, TP AND LF/ HF 
RATIO 
     BMI and WC shows significant negative correlation with SDNN                  
(-0.336, p<0.01), (-0.303, P<0.05) and total power (-0.405, p<0.01), (-0.347, 
p<0.01) and positive correlation with LF/HF ratio (+0.603, p<0.01), (+0.618, 
p<0.01).  
 WHR also positively correlated with LF/HF ratio (+0.51, p<0.01) and 
negatively correlated with total power (-0.291, p<0.05) significantly and with 
SDNN insignificantly (-0.246, p=0.058). 
            The findings was  in accordance with results observed by Rajalakshmi 
et al78 (2014), that the anthropometric measurement BMI, WC and WHR was 
negatively correlated with SDNN and Total power and positively correlated 
with LF/HF ratio.  
Correlation of Anthropometric Indices with E/I Ratio and Valsalva Ratio: 
              In this study, BMI was negatively correlated with E/ I ratio and 
Valsalva ratio significantly (-0.44, p<0.01), (-0.344, P<0.01). 
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             WC and WHR also shows negative correlation with E/ I ratio 
significantly (-0.433, p<0.01) (-0.424, p<0.01) and Valsalva ratio 
insignificantly (-0.254, p=0.05) (0.22, P>0.05). 
            According to Shahin Akhter et al (2008)38, that BMI and WC were 
negatively correlated with E/I ratio and Valsalva ratio significantly.  
Nerella sharvani et al69 (2015) also observed significant negative correlation of 
BMI and WHR with E/I and Valsalva ratio in their Studies. 
  Correlation of Anthropometric Indices with Isometric Hand Grip test: 
            In our study, BMI was negatively correlated with rise of DBP 
significantly (-0.262, p<0.05) and rise of SBP insignificantly (-0.207, P>0.05).  
            WC and WHR also negatively correlated with rise of SBP and DBP 
though not significant  
           Kalpana B et al70 (2015) also noticed negative correlation of BMI and 
rise in DBP significantly. This shows sympathetic response to isometric 
exercise decreases as body fat increases.   
CORRELATION OF LIPID PROFILE WITH CARDIOVASCULAR 
AUTONOMIC FUNCTION TEST 
Correlation of Lipid Profile with SDNN, TP  and LF/ HF RATIO: 
            In this study, TC, TGL and LDL were positively correlated with 
LF/HF ratio significantly (+0.53, p<0.01) (+0.488, p<0.01) (+0.582, p<0.01).  
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           TC and LDL also shows negative correlation with SDNN and TP 
significantly (-0.26, p<0.05) (-0.285, p<0.05) and (-0.284, p<0.05) (-0.322, 
p<0.05)   
           TGL shows negative correlation with SDNN and TP non-significantly 
(-0.213, p>0.05), (-0.25, p>0.05).  
           HDL shows significant negative correlation with LF/HF ratio (-0.309, 
p<0.05) also correlated positively with SDNN and TP though not significant 
(+0.142, p>0.05), (+0.203, p>0.05).  
Correlation of Lipid Profile with E/I Ratio and Valsalva Ratio: 
 In this study, TC and LDL were negatively correlated with E/I ratio and 
Valsalva ratio significantly (-0.376, p<0.01) (-0.405, p<0.01) and (-0.297, 
p<0.05) (-0.27, p<0.05). 
           TGL was negatively correlated with E/I ratio significantly (-0.36, 
p<0.01) and Valsalva ratio non-significantly. 
          Whereas HDL was positively correlated with E/I ratio and Valsalva 
ratio though not significant.  
 According to Arunima Chaudhuri et al 85 (2012) TC, TGL and LDL 
were negatively correlated with E/I ratio and Valsalva ratio.  HDL was 
positively correlated with E/I ratio and Valsalva ratio. 
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Correlation of Lipid Profile with Isometric Hand Grip test: 
           TC was negatively correlated with rise of DBP significantly (-0.282, 
P<0.01) and SBP insignificantly in isometric hand grip exercise. 
          TGL and LDL were negatively correlated with rise of SBP and DBP but 
not significant. Whereas HDL was   positively correlated with rise of SBP and 
DBP though not significant.   
          According to Arunima Chaudhuri et al86 (2015) TC, TGL and LDL were 
negatively correlated with isometric hand grip test and HDL was positively 
correlated with isometric response. 
           This shows lipids plays a role in modulation of autonomic activity and 
the autonomic activity decreases in proportion to increase TC, TGL, LDL and 
decrease HDL. In obesity there is adverse pattern of plasma lipoproteins, high 
triglycerides, low HDL and abnormal LDL composition. This abnormal lipid 
profile causes impairment of endothelium dependent arteriolar dilatation in the 
vessel wall and changes baroreflex capacity. Though elevated LDL is not a 
component of metabolic syndrome, small dense LDL formed in obesity is 
highly atherogenic and increases cardiovascular risk. Thus in proportion to 
increase in LDL, vagal activity and baroreflex capacity reduces which 
increases coronary artery disease morbidity and mortality in obesity. 
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CONCLUSION 
 
              The present study shows that there is a positive association between 
higher serum total cholesterol, triglycerides, LDL cholesterol and reduced 
HDL cholesterol with increased BMI. This is an independent predictor of 
cardiovascular risk 
Cardiovascular autonomic function test in obese male individuals shows 
           Increase BMI is associated with rise in resting heart rate, blood 
pressure, LF nu and LF/HF ratio of frequency domain measures of resting 
HRV in obese group compared to non-obese group. This indicates an increase 
in the cardiac sympathetic activity at resting conditions in obese individuals  
          Mean RR, SDNN, RMSSD, NN50 and pNN50% of time domain 
measures and TP and HF nu of frequency domain measures of resting HRV 
decrease in obese group compared to non-obese group.  
           E/I ratio of deep breathing and Valsalva ratio also decreases in obese 
group compared to non-obese group. This shows decrease in cardiac 
parasympathetic activity at rest in obese group.   
          Though sympathetic activity increases in obese males as evidenced by 
increase baseline HR, BP and LF nu of HRV, the sympathetic response to 
isometric exercise decreased in obese group which reflects autonomic 
instability. 
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         All these factors indicates sympathovagal imbalance at rest in obese 
male individuals in the form of increased sympathetic and decreased 
parasympathetic activity. This sympathovagal imbalance makes them 
susceptible to develop cardiovascular dysfunction. 
           So lipid profile estimation and cardiovascular autonomic function test 
should be carried out in obesity as early as possible to identify the individuals 
at risk for cardiovascular disease. Lifestyle modification in the form of regular 
exercise, practicing yoga and also dietary modification are suggested to reduce 
the weight and to shift the sympathovagal balance in favour of vagal 
predominance to prevent cardiovascular dysfunction in obesity. 
Limitation  
 To find the risk of metabolic syndrome in apparently healthy obese 
individual’s insulin resistance and glucose tolerance test is to be carried out. 
          Studies based on duration of obesity and effect of weight loss on cardiac 
autonomic activity is to be carried out.  
          Effect of obesity on cardiac autonomic activity can be studied more  
significantly by evaluating insulin resistance and leptin level 
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SUMMARY 
 
               The study aims at evaluation and comparison of lipid profile and 
cardiovascular autonomic function in obese male individuals with that of 
healthy normal individuals of age group 25-40 years. 
The following Autonomic function tests were performed. 
1. Heart rate variability at supine rest 
2. Heart rate changes at one minute controlled deep breathing (E/I 
RATIO) 
3. Heart rate changes during Valsalva maneuver 
4.  Blood pressure response to Sustained isometric handgrip exercise. 
The following results were obtained:-  
  Lipid profile estimation shows significant increase in serum TC, TGL, 
LDL and decrease HDL in obese male. 
Autonomic function test shows  
Significant increase in the resting heart rate.  
 Significant reduction in SDNN and HF nu in resting HRV indicating 
parasympathetic withdrawal. 
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 Significant increase in the LF nu and LF/HF ratio indicates sympathetic 
over activity under resting conditions. 
 Also shows decrease in E/I ratio of Deep Breathing and Valsalva Ratio 
of Valsalva maneuver which implies reduced parasympathetic function and 
baroreflex activity in obesity. 
          Decrease in rise of SBP and DBP in response to Sustained isometric 
handgrip exercise shows reduced sympathetic activity at stress and autonomic 
instability in obesity.  
          Cardiovascular autonomic function, when tested using standard 
autonomic function tests were significantly altered in obese male individuals. 
Hence autonomic function tests including HRV may be used as a tool to 
diagnose autonomic dysfunction earlier.  This to take effective measures 
earlier to prevent obesity associated morbidity and mortality. 
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ANNEXURES 
APPENDIX - A 
Name      Height 
Age      Weight 
Sex      Occupation 
 
No. Autonomic Symptoms  Yes No. 
1. Nasal symptoms a. drynose 
b. running nose 
  
2. Sweating symptoms a. Increased 
b. Decreased 
  
3. Postural fall/dizziness on 
standing 
   
4. GIT Symptoms a. Diarrhoea 
b. Constipation 
d. Discomfort/pain 
  
5. Headache/Migraine / 
(Heaviness of head 
throbbing headache) 
   
6. Micturition disturbances a. Frequency 
b. Urgency 
c. Incontinence  
d. Nocturia 
e. Hesitancy  
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7. Occasional attacks of 
bronchospasm (after 
exercise, laughter, or 
emotion) 
   
8. Do u feel hot or cold    
9. Do your extremities 
remain 
a. Warm 
b. Cold 
  
10. Burning feet    
11. Risk factors a. Obesity 
b. Hypertension 
c. Diabetes Mellitus 
d. CHD 
e. Smoking 
f. Alcoholism 
  
12. Any stress related 
physical symptoms 
(flushing, choking, 
laump in the throat, 
general weakness) 
   
13. Any other general 
symptoms 
   
14. Allergy to any drug    
14. Physical 
status 
Regular 
athlete 
Occ.player/ 
sedentary 
Regular 
exercise 
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       HRV5 min 
SUPPINE REST 
ONE MINUTE 
CONTROLLED DEEP 
BREATHING 
Time domain measures Mean HR 
Mean RR 
SDNN 
RMSSD 
NN50 
pNN50 
SDNN 
Frequency domain 
measures 
Total power  
LFnu 
HFnu 
LF/HF Ratio 
HFnu 
  E/I Ratio 
         Max RR 
         Interval 
        Min RR 
        Interval 
Valsalva Ratio 
Max RR 
Interval 
Min RR 
Interval 
Isometric Hand Grip 
Systolic BP 
Difference 
Diastolic BP 
Difference. 
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MASTER CHART 
ANTHROPOMETRIC CHARACTERISTIC, LIPID PROFILE AND 
BASELINE BLOOD PRESSURE IN STUDY GROUP 
S.No 
AGE 
in 
years 
WTK
g 
HT 
cm 
HT 
m 
BMI 
kg/m2 
WC 
cm 
HC 
cm 
WHR 
TC 
mg/dl 
TGL 
mg/dl 
HDL 
mg/dl 
LDL 
mg/dl 
SBP 
mmH
g 
DBP 
mm 
Hg 
PP 
mm 
Hg 
MAP 
mm Hg 
O1 33 82 162 1.62 31 91 96 0.94 199 169 44 121 118 74 44 88.67 
O2 37 87 162 1.62 33 92 97 0.94 195 177 44 116 122 74 48 90 
O3 39 82 165 1.65 30 92 99 0.92 198 172 42 122 126 80 46 95.33 
O4 35 76 161 1.61 29 91 99 0.91 176 157 43 102 124 76 48 92 
O5 32 78 164 1.64 29 91 97 0.93 171 158 42 100 120 76 44 90.67 
O6 32 90 176 1.76 29 91 99 0.91 186 169 41 111 120 70 50 86.67 
O7 34 87 167 1.67 31 93 100 0.93 192 172 41 117 120 72 48 88 
O8 34 82 165 1.65 30 91 95 0.95 179 163 40 104 120 78 42 92 
O9 36 77 161 1.61 29 89 95 0.93 185 165 42 110 118 74 44 88.67 
O10 32 79 166 1.66 28 87 95 0.91 169 144 39 101 114 70 44 84.67 
O11 35 82 166 1.66 29 92 97 0.94 180 166 40 105 118 74 44 88.67 
O12 31 91 178 1.78 28 92 96 0.95 189 163 43 114 116 68 48 84 
O13 32 72 157 1.57 29 87 93 0.93 170 149 42 98 114 78 36 90 
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S.No 
AGE 
in 
years 
WTK
g 
HT 
cm 
HT 
m 
BMI 
kg/m2 
WC 
cm 
HC 
cm 
WHR 
TC 
mg/dl 
TGL 
mg/dl 
HDL 
mg/dl 
LDL 
mg/dl 
SBP 
mmH
g 
DBP 
mm 
Hg 
PP 
mm 
Hg 
MAP 
mm Hg 
O14 34 82 167 1.67 29 90 99 0.9 174 154 44 99 122 80 42 94 
O15 35 74 167 1.67 26 87 95 0.91 164 142 41 95 118 76 42 90 
O16 36 78 162 1.62 29 92 99 0.92 186 162 41 113 120 74 46 89.33 
O17 34 86 170 1.7 29 91 101 0.9 173 149 43 100 126 82 44 96.67 
O18 33 76 164 1.64 28 90 101 0.89 180 152 42 108 122 80 42 94 
O19 34 82 166 1.66 29 92 91 1.01 190 174 42 113 124 78 46 93.33 
O20 29 76 161 1.61 29 88 96 0.91 177 155 44 100 128 80 48 96 
O21 30 97 179 1.79 30 91 97 0.93 188 165 47 110 114 72 42 86 
O22 36 80 170 1.7 27 89 94 0.94 172 149 42 100 120 78 42 92 
O23 35 73 162 1.62 27 85 90 0.94 175 150 44 101 118 78 40 91.33 
O24 32 76 160 1.6 29 87 95 0.91 188 145 45 114 120 72 48 88 
O25 38 81 165 1.65 29 89 96 0.92 190 153 43 117 128 84 44 98.67 
O26 33 68 157 1.57 27 85 94 0.9 170 148 44 97 126 78 48 94 
O27 34 71 156 1.56 29 91 97 0.93 185 164 41 111 122 80 42 94 
O28 29 72 167 1.67 25 86 95 0.9 164 142 45 91 116 70 46 85.33 
O29 30 78 165 1.65 28 90 99 0.9 173 152 44 99 128 82 46 97.33 
O30 28 81 175 1.75 26 83 92 0.9 160 143 42 90 114 74 40 87.33 
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ANTHROPOMETRIC CHARACTERISTIC, LIPID PROFILE AND BASELINE  BLOOD PRESSURE IN CONTROL 
GROUP 
S.NO 
AGE      
in 
years 
WT 
Kg 
HT 
cm 
HT 
m 
BMI 
kg/m2 
WC 
cm 
HC 
cm WHR 
TC 
mg/dl 
TGL 
mg/dl 
HDL 
mg/dl 
LDL 
mg/dl 
SBP 
mm
Hg 
DBP 
mmH
g 
PP 
mm
Hg 
MAP 
C1 30 64 164 1.64 23 80 92 0.86 172 147 47 96 120 84 36 96 
C2 32 54 169 1.69 18 72 84 0.85 146 133 41 80 118 74 44 88.67 
C3 34 62 169 1.69 21 74 86 0.86 154 118 47 83 116 70 46 85.33 
C4 39 54 165 1.65 19 72 83 0.86 147 115 43 81 122 80 42 94 
C5 30 70 169 1.69 24 83 95 0.87 179 154 48 100 126 82 44 96.67 
C6 31 70 172 1.72 23 85 92 0.92 179 161 40 107 118 78 40 91.33 
C7 35 62 162 1.62 23 78 89 0.87 157 126 47 85 108 70 38 82.67 
C8 33 54 160 1.6 21 72 83 0.86 153 127 46 82 96 62 34 73.33 
C9 32 65 167 1.67 23 86 91 0.94 181 162 47 102 114 68 46 83.33 
C10 36 58 158 1.58 23 82 92 0.89 168 147 42 97 106 76 30 86 
C11 28 64 164 1.64 23 78 88 0.88 161 140 44 89 124 76 48 92 
C12 30 68 170 1.7 23 78 89 0.87 167 144 45 93 106 66 40 79.33 
C13 29 58 160 1.6 22 77 86 0.89 160 142 42 90 114 68 46 83.33 
C14 30 62 169 1.69 21 76 87 0.87 166 145 48 89 120 84 36 96 
C15 34 68 169 1.69 23 80 88 0.9 167 141 43 96 120 76 44 90.67 
C16 36 67 170 1.7 23 85 92 0.92 179 157 45 103 108 76 32 86.67 
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S.NO 
AGE      
in 
years 
WT 
Kg 
HT 
cm 
HT 
m 
BMI 
kg/m2 
WC 
cm 
HC 
cm WHR 
TC 
mg/dl 
TGL 
mg/dl 
HDL 
mg/dl 
LDL 
mg/dl 
SBP 
mm
Hg 
DBP 
mmH
g 
PP 
mm
Hg 
MAP 
C17 38 54 162 1.62 20 73 84 0.86 146 126 41 80 114 62 52 79.33 
C18 34 67 171 1.71 22 76 86 0.88 161 137 44 90 104 60 44 74.67 
C19 35 57 170 1.7 19 72 83 0.86 159 119 52 84 110 74 36 86 
C20 29 66 167 1.67 23 84 94 0.89 169 148 41 97 112 78 34 89.33 
C21 30 60 174 1.74 19 74 84 0.88 152 127 45 81 90 58 32 68.67 
C22 29 61 165 1.65 22 74 84 0.88 157 125 44 88 118 70 48 86 
C23 33 67 171 1.71 22 74 86 0.86 162 135 46 89 114 78 36 90 
C24 35 68 169 1.69 23 84 95 0.88 175 153 45 100 98 62 36 74 
C25 29 60 170 1.7 20 72 84 0.85 153 126 44 84 114 66 48 82 
C26 30 61 163 1.63 22 76 84 0.9 164 139 42 94 110 66 44 80.67 
C27 33 70 171 1.71 23 82 95 0.86 162 142 45 89 118 76 42 90 
C28 31 56 168 1.68 19 76 86 0.88 152 134 45 84 118 70 48 86 
C29 34 65 167 1.67 23 81 94 0.86 174 149 47 97 116 70 46 85.33 
C30 32 63 168 1.68 22 77 89 0.86 163 151 43 90 110 72 38 84.67 
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HRV IN SUPINE REST-STUDY GROUP 
S.no 
MEAN    
HR 
bpm 
MEAN RR 
ms SDNN ms 
RMSSDN 
ms NN50 
pNN50 
(%) 
Total 
power LF/HF LF nu HF nu 
O1 72.41 830.5 26.1 18.1 14 3.9 348 4.837 82.8 17.1 
O2 79.06 759.2 9.6 6.4 0 0 94 4.065 80.2 19.7 
O3 88 684.1 22.1 13.9 9 2.1 327 6.433 86.5 13.4 
O4 78.86 764.5 32.65 24.25 28 7.12 1187 4.6318 82.133 17.73 
O5 77.67 773.5 18.3 13.2 8 2.1 113 3.618 78.3 21.6 
O6 73.52 817.2 19.1 14.4 4 1.1 289 4.308 81.1 18.8 
O7 71.87 836 17.4 11.6 2 0.6 281 4.386 81.4 18.6 
O8 68.03 884.2 30.7 25.1 23 6.8 520 3.326 76.8 23.1 
O9 66.54 902.6 15.9 13.1 4 1.2 260 4.152 80.4 19.4 
O10 65.38 918.7 20 17.4 7 2.1 155 4.201 80.6 19.2 
O11 65.29 920.9 26.3 21.2 13 4 585 3.581 78 21.8 
O12 63.7 945.3 27.3 20.8 14 4.4 775 5.185 83.8 16.2 
O13 61.92 970.7 25.7 20.8 16 5.2 643 3.748 78.8 21 
O14 72.13 835.9 36.9 28.9 26 7.3 1343 4.451 81.5 18.3 
O15 70.06 859.6 27.7 20.8 22 6.3 1003 3.929 79.7 20.3 
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S.no 
MEAN    
HR 
bpm 
MEAN RR 
ms SDNN ms 
RMSSDN 
ms NN50 
pNN50 
(%) 
Total 
power LF/HF LF nu HF nu 
O16 65.56 922.2 43.8 33.7 33 10.2 2100 5.026 83.3 16.6 
O17 83.84 717.1 22.5 15.8 11 2.6 302 2.713 73.1 26.9 
O18 77.69 773.1 16.4 12.2 5 1.3 358 4.653 82.2 17.7 
O19 79.97 751.3 13.6 9.2 3 0.8 95 4.746 82.6 17.4 
O20 86.33 696.5 16.4 11.2 1 0.2 219 2.815 73.8 26.2 
O21 71.9 836 24.9 19 14 3.9 790 4.375 81.3 18.6 
O22 88.7 678.5 24.4 17.7 16 3.6 683 2.836 73.9 26.1 
O23 75.64 797.2 53.1 44.5 36 9.6 4057 4.004 80 20 
O24 66.68 900.8 18.6 13.7 5 1.5 342 5.389 84.3 15.6 
O25 83.34 720.8 19.9 13.1 8 1.9 410 6.516 86.6 13.3 
O26 89.86 668.1 10.2 7.5 0 0 103 2.954 74.6 25.3 
O27 81.84 735.7 14.3 9.7 2 0.5 230 4.751 82.6 17.4 
O28 71.13 844.2 18 14.1 4 1.1 340 3.934 79.7 20.2 
O29 81.9 741.2 23.5 16 11 2.7 604 5.958 85.6 14.4 
O30 73.93 815.3 19.7 13.7 6 1.6 296 4.021 80.1 19.9 
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HRV IN SUPINE REST-CONTROL GROUP 
S.No 
MEAN 
HR 
bpm 
MEAN 
RR 
ms 
SDNN 
ms 
RMSSDN 
ms NN50 
p NN50 
(%) 
Total 
power LF/HF LF nu HF nu 
C1 73.94 813.3 24 18.1 13 3.5 676 3.171 76 24 
C2 69.72 861.3 18.7 15.2 10 2.9 409 3.252 76.4 23.5 
C3 68.43 877.6 18.7 14.4 7 2 546 4.122 78.4 19.5 
C4 74.6 805.5 23.5 19 11 3 503 2.956 74.6 25.2 
C5 63.68 949.8 58.4 46.7 32 10.2 2567 1.991 66.5 33.4 
C6 77.56 777.9 48.9 38.3 47 12.2 2184 3.174 76 23.9 
C7 69.98 859.2 25.3 19.9 13 3.7 526 3.459 77.5 22.4 
C8 71.92 842.6 41.3 32.3 34 9.6 1559 3.29 76.7 23.3 
C9 68.43 878 22.9 18.2 10 2.9 790 2.562 71.9 28.1 
C10 64.98 926 26 21.5 15 4.6 1013 3.08 75.5 24.5 
C11 72.58 834.4 45.1 35.1 40 11.1 1717 2.194 68.6 31.3 
C12 83.28 721.5 19.7 14.8 8 1.9 300 2.352 70.2 29.8 
C13 68.8 875.4 46.3 39.9 49 11.8 1290 3.336 76.7 23 
C14 82.16 736.2 34.9 25.6 26 6.4 1165 3.127 75.8 24.2 
C15 86.22 697 17.3 12.3 1 0.2 232 1.47 59.5 40.5 
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S.No 
MEAN 
HR 
bpm 
MEAN 
RR 
ms 
SDNN 
ms 
RMSSDN 
ms NN50 
p NN50 
(%) 
Total 
power LF/HF LF nu HF nu 
C16 65.26 920.7 19.4 16.5 14 4.3 289 2.922 74.5 25.6 
C17 68.99 871.4 25.4 21.9 11 3.2 648 2.514 71.4 28.4 
C18 71.13 845.6 23.4 18.8 16 4.5 565 2.922 74.3 25.4 
C19 75.01 801 28.3 21.4 24 6.4 591 2.504 71.4 28.5 
C20 70.23 861.1 50.9 40.3 38 10.9 2881 3.164 75.8 24 
C21 64.36 936.1 41.6 33.8 39 12.2 1404 3.363 77 22.9 
C22 73.8 815.3 33.9 24.4 21 5.7 830 3.414 77.3 22.6 
C23 69.65 869.6 51 39 36 10.5 2256 2.556 71.8 28.1 
C24 70.02 859.9 21.6 16.1 10 2.9 411 2.894 74.2 25.7 
C25 70.16 856.2 16 11.1 1 0.3 187 2.884 74.2 25.7 
C26 66.47 906.1 44.2 37.1 27 8.2 1469 2.574 71.9 27.9 
C27 70.99 850.5 36.9 25.4 17 4.9 1386 1.943 65.9 33.9 
C28 71.8 841.1 43.8 35.9 43 12.1 2542 3.114 75.6 24.3 
C29 70.39 860.2 58.1 46.9 29 8 1242 2.985 74.8 25.1 
C30 66.72 903.4 36.3 27.8 19 5.7 1390 3.43 77.3 22.5 
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DEEP BREATHING TEST E/I RATIO, VALSALVARATIO AND ISOMETRIC HAND GRIP TEST IN STUDY 
GROUP 
S.No MEAN HR bpm 
MEAN RR 
ms 
SDNN 
ms HF nu E/I RATIO 
VALSALVA 
RATIO 
SBP 
DIFFERENCE 
mmHg 
DBP 
DIFFERENCE 
mmHg 
O1 70.12 859.9 58.3 30.8 1.118 1.179 8 10 
O2 81.25 740.1 28.3 39.4 1.064 1.084 12 12 
O3 83.79 717.6 33.3 26.5 1.069 1.417 10 14 
O4 79.97 753 40.6 27.9 1.15 1.386 6 8 
O5 72.89 829 64.8 28.6 1.176 1.531 14 16 
O6 70.69 853.7 48.2 31.3 1.088 1.048 12 8 
O7 81.44 740.6 50.7 18.9 1.129 1.153 14 12 
O8 63.25 969.3 132.1 22.9 1.18 1.176 10 10 
O9 73.62 818.9 47.5 28.9 1.111 1.537 8 12 
O10 62.16 969 53.7 27.6 1.088 1.93 10 12 
O11 67.76 892.6 73.8 31.5 1.18 1.361 10 14 
O12 63.82 952.6 100.8 17.3 1.295 1.672 10 10 
O13 62.75 969.2 108.2 26.4 1.202 1.121 14 14 
O14 72.83 844.3 122.4 36.9 1.354 1.174 16 12 
O15 71.43 851.5 93.8 33.9 1.282 1.61 8 10 
115 
 
S.No MEAN HR bpm 
MEAN RR 
ms 
SDNN 
ms HF nu E/I RATIO 
VALSALVA 
RATIO 
SBP 
DIFFERENCE 
mmHg 
DBP 
DIFFERENCE 
mmHg 
O16 69.22 902 154.1 32.4 1.469 1.294 8 8 
O17 85.66 703.9 33.9 25.1 1.131 1.648 10 14 
O18 76.16 793.1 60.9 41.4 1.276 1.088 16 12 
O19 77.32 783 69.6 25.7 1.202 1.4 8 4 
O20 77.37 786.1 85.8 31 1.276 1.088 8 8 
O21 79.62 762.5 54.9 31.1 1.108 1.287 6 6 
O22 91.84 654.2 21.7 48.5 1.158 1.359 10 12 
O23 64.06 962 144.4 26.4 1.487 1.436 8 14 
O24 62.84 967 105.3 28.9 1.264 1.385 10 8 
O25 85.53 702.8 25.3 19 1.073 1.044 8 8 
O26 94.04 643.2 46.7 42.3 1.033 1.104 12 8 
O27 79.73 758.7 64.3 34.3 1.193 1.06 8 12 
O28 77.03 782 38.3 37.2 1.13 1.276 14 12 
O29 85.68 703.5 39 24 1.121 1.434 8 12 
O30 73.96 820.2 86 43.7 1.251 1.216 10 12 
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DEEP BREATHING TEST E/I RATIO, VALSALVARATIO AND ISOMETRIC HAND GRIP TEST IN CONTROL 
GROUP 
 
SNO MEAN HR bpm 
MEAN RR 
ms 
SDNN 
ms HF nu 
E/I 
RATIO 
VALSALVA 
RATIO 
SBP 
DIFFERENCE 
mmHg 
DBP 
DIFFERENCE 
mmHg 
C1 80.68 760.6 94.9 31.7 1.226 1.208 10 10 
C2 87.23 707.5 88.2 39.3 1.243 1.949 16 14 
C3 70.15 861.4 61.8 33.4 1.154 1.288 8 10 
C4 74.4 816.5 84.9 33.4 1.251 1.317 8 8 
C5 81.91 755.2 121.6 80.5 1.524 1.415 16 10 
C6 70.46 892.2 185.1 35.5 1.126 1.575 10 14 
C7 71.34 863.8 133.2 37.8 1.404 1.4983 14 18 
C8 83.17 739.2 115.4 39.5 1.361 2.352 8 14 
C9 72.44 833.1 56.1 30.7 1.118 1.282 10 12 
C10 73.7 832.4 123 28.5 1.334 1.26 16 16 
C11 82 748.7 108.2 35.9 1.366 1.754 10 16 
C12 83.89 729.2 89.6 33.3 1.29 1.375 10 8 
C13 76.93 796.9 100.9 26.3 1.27 1.385 10 14 
C14 70.91 862.9 118.5 37.6 1.358 1.507 8 12 
C15 89.53 673.4 43.4 57 1.27 1.476 10 8 
C16 67.24 900 71.3 27.7 1.167 1.874 16 16 
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SNO MEAN HR bpm 
MEAN RR 
ms 
SDNN 
ms HF nu 
E/I 
RATIO 
VALSALVA 
RATIO 
SBP 
DIFFERENCE 
mmHg 
DBP 
DIFFERENCE 
mmHg 
C17 75.32 806 74.7 23.7 1.192 1.294 10 10 
C18 83.11 729.3 66.6 36.8 1.219 1.144 8 12 
C19 77.91 780.1 65.8 35.2 1.18 1.202 18 14 
C20 76.04 814.4 106.9 38.2 1.326 1.451 20 14 
C21 57.49 1051.6 75.2 23.1 1.145 1.409 20 16 
C22 70.36 867.9 107 35.9 1.285 1.144 16 16 
C23 80.08 760.8 88.7 37.2 1.304 1.521 12 10 
C24 67.23 916.1 142.6 31.3 1.409 1.31 18 14 
C25 80.33 764.6 114.4 35.5 1.4 1.716 8 14 
C26 61.8 988.8 122.2 23.9 1.318 1.381 10 8 
C27 74.86 809.5 61.1 40.8 1.141 1.4752 8 10 
C28 80.21 763.2 95.7 34 1.433 1.878 12 10 
C29 68.55 896.8 122.9 39.7 1.305 1.4841 10 14 
C30 76.95 810.6 114.4 31.6 1.373 1.22 18 14 
 
 
